05.07.2014 Views

Opting out of Statutory Health Insurance in Germany and the ... - SFI

Opting out of Statutory Health Insurance in Germany and the ... - SFI

Opting out of Statutory Health Insurance in Germany and the ... - SFI

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

FIRST DRAFT ONLY – PLEASE DO NOT CITE<br />

<strong>Opt<strong>in</strong>g</strong> <strong>out</strong> <strong>of</strong> statutory health <strong>in</strong>surance: <strong>the</strong> case <strong>of</strong> <strong>Germany</strong><br />

<strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s<br />

Sarah Thomson* <strong>and</strong> Elias Mossialos**<br />

* Research Officer, European Observatory on <strong>Health</strong> Care Systems <strong>and</strong> Research Officer <strong>in</strong><br />

<strong>Health</strong> Policy, LSE <strong>Health</strong> <strong>and</strong> Social Care (correspond<strong>in</strong>g author)<br />

** Reader <strong>in</strong> <strong>Health</strong> Policy, Department <strong>of</strong> Social Policy, LSE <strong>and</strong> Co-Director <strong>of</strong> LSE <strong>Health</strong><br />

<strong>and</strong> Social Care<br />

Acknowledgements<br />

The authors are grateful to Annemarie Ter L<strong>in</strong>den <strong>and</strong> Marieke Datema for <strong>the</strong>ir assistance<br />

with documents <strong>in</strong> Dutch <strong>and</strong> German.<br />

Address for correspondence:<br />

Sarah Thomson<br />

J301, LSE <strong>Health</strong> <strong>and</strong> Social Care, LSE, Houghton Street, London WC2 2AE<br />

Email: s.thomson@lse.ac.uk<br />

Tel: +44-20-7955-6474 / Fax: +44-20-7955-6803


<strong>Opt<strong>in</strong>g</strong> <strong>out</strong> <strong>of</strong> statutory health <strong>in</strong>surance: <strong>the</strong> case <strong>of</strong> <strong>Germany</strong><br />

<strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s<br />

Introduction<br />

People liv<strong>in</strong>g <strong>in</strong> <strong>the</strong> European Union (EU) rarely purchase private or voluntary health<br />

<strong>in</strong>surance (VHI) as a substitute for health <strong>in</strong>surance provided by <strong>the</strong> state. This is because<br />

statutory health <strong>in</strong>surance usually covers <strong>the</strong> whole population. Exceptions to this trend are<br />

only found <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, where levels <strong>of</strong> statutory health <strong>in</strong>surance<br />

coverage are as low as 92.2 <strong>and</strong> 75.6 per cent respectively (Organisation for Economic Cooperation<br />

<strong>and</strong> Development 2002).<br />

Unlike o<strong>the</strong>r EU member states, governments <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s exclude a<br />

significant proportion <strong>of</strong> <strong>the</strong> population from – or allow specific groups <strong>of</strong> people to opt <strong>out</strong> <strong>of</strong> –<br />

<strong>the</strong> statutory health <strong>in</strong>surance scheme. Those who are excluded from statutory coverage can<br />

purchase ‘substitutive’ VHI from private health <strong>in</strong>surers if <strong>the</strong>y require protection from <strong>the</strong><br />

f<strong>in</strong>ancial consequences <strong>of</strong> ill health. Those who are permitted to opt <strong>out</strong> can choose between<br />

statutory <strong>and</strong> substitutive VHI coverage; opt<strong>in</strong>g for <strong>the</strong> latter exempts <strong>the</strong>m from mak<strong>in</strong>g<br />

f<strong>in</strong>ancial contributions to <strong>the</strong> statutory health <strong>in</strong>surance scheme i .<br />

It is <strong>of</strong>ten argued that governments <strong>in</strong> o<strong>the</strong>r European countries should adopt <strong>the</strong> German or<br />

Dutch model <strong>and</strong> exclude people from or allow <strong>the</strong>m to opt <strong>out</strong> <strong>of</strong> some or all aspects <strong>of</strong> <strong>the</strong><br />

statutory health <strong>in</strong>surance scheme (Blackwell <strong>and</strong> Kruger 2002; Howard 2003). At <strong>the</strong> time <strong>of</strong><br />

writ<strong>in</strong>g, for example, <strong>the</strong> Italian, Slovakian <strong>and</strong> Russian governments are seriously<br />

consider<strong>in</strong>g <strong>the</strong> <strong>in</strong>troduction <strong>of</strong> an opt <strong>out</strong> policy.<br />

Two assumptions underlie arguments <strong>in</strong> favour <strong>of</strong> exclusion <strong>and</strong> opt <strong>out</strong> policies. First, that<br />

public resources for health care are limited <strong>and</strong> overstretched. If more people, particularly<br />

those with higher <strong>in</strong>comes, are given <strong>the</strong> opportunity or compelled to take f<strong>in</strong>ancial<br />

responsibility for <strong>the</strong>ir own health protection, public expenditure on health care will fall, relative<br />

to private expenditure, <strong>and</strong> <strong>the</strong> government will be able to devote a larger share <strong>of</strong> its<br />

resources to provid<strong>in</strong>g health care for poorer people. Second, that <strong>in</strong>creased choice for<br />

consumers <strong>and</strong> <strong>the</strong> threat <strong>of</strong> voluntary exit from <strong>the</strong> statutory health <strong>in</strong>surance scheme will<br />

stimulate competition between statutory <strong>and</strong> private health <strong>in</strong>surers, lead<strong>in</strong>g to efficiency<br />

ga<strong>in</strong>s <strong>and</strong> improved quality <strong>in</strong> <strong>the</strong> health system as a whole.<br />

1


In practice, however, exclusion <strong>and</strong> opt <strong>out</strong> policies are not as straightforward as <strong>the</strong>y at first<br />

appear to be. They may also conflict with health system objectives. Due to differences <strong>in</strong> <strong>the</strong><br />

way <strong>in</strong> which statutory <strong>and</strong> private health <strong>in</strong>surers operate, <strong>the</strong> possibility <strong>of</strong> voluntary exit<br />

from <strong>the</strong> statutory health <strong>in</strong>surance scheme is likely to threaten its f<strong>in</strong>ancial stability: private<br />

health <strong>in</strong>surers are able to attract younger <strong>and</strong> healthier people, leav<strong>in</strong>g <strong>the</strong> state to cover an<br />

adverse selection <strong>of</strong> older people <strong>and</strong> people <strong>in</strong> poor health. As a result <strong>of</strong> <strong>the</strong> correlation<br />

between health status, age <strong>and</strong> <strong>in</strong>come, a similar situation may arise when higher <strong>in</strong>come<br />

people are excluded from statutory coverage. In ei<strong>the</strong>r case, <strong>the</strong> burden <strong>of</strong> rais<strong>in</strong>g revenue to<br />

fund <strong>the</strong> statutory health <strong>in</strong>surance scheme will fall disproportionately on people with lower<br />

<strong>in</strong>comes <strong>and</strong> lower levels <strong>of</strong> health, unless this revenue is subsidised through taxation or<br />

m<strong>and</strong>atory contributions from those covered by substitutive VHI. Exclusion <strong>and</strong> opt <strong>out</strong><br />

policies may <strong>the</strong>refore underm<strong>in</strong>e levels <strong>of</strong> solidarity between those with high <strong>and</strong> low<br />

<strong>in</strong>comes <strong>and</strong> between those at high <strong>and</strong> low risk <strong>of</strong> ill health.<br />

A fur<strong>the</strong>r issue concerns <strong>the</strong> behaviour or conduct <strong>of</strong> <strong>in</strong>surers <strong>in</strong> a market for private health<br />

<strong>in</strong>surance. Private health <strong>in</strong>surers generally operate <strong>in</strong> an environment that gives <strong>the</strong>m<br />

considerable freedom from government <strong>in</strong>tervention, relative to statutory <strong>in</strong>surers. It could be<br />

argued that this freedom is a necessary pre-requisite for <strong>the</strong> smooth function<strong>in</strong>g <strong>of</strong> a<br />

competitive market. However, private health <strong>in</strong>surance is characterised by a number <strong>of</strong><br />

market failures, so unless it is subject to some degree <strong>of</strong> regulation, it is likely to be an<br />

<strong>in</strong>efficient <strong>and</strong> <strong>in</strong>equitable means <strong>of</strong> fund<strong>in</strong>g health care (Barr 1992). Certa<strong>in</strong> aspects <strong>of</strong><br />

market conduct may restrict choice for some consumers, particularly older people <strong>and</strong> people<br />

<strong>in</strong> poor health, <strong>and</strong> prevent <strong>the</strong>m from obta<strong>in</strong><strong>in</strong>g an affordable <strong>and</strong> adequate level <strong>of</strong><br />

substitutive VHI cover. This is <strong>of</strong> particular importance <strong>in</strong> <strong>the</strong> context <strong>of</strong> a market for<br />

substitutive VHI, given its role <strong>in</strong> provid<strong>in</strong>g people with protection from <strong>the</strong> f<strong>in</strong>ancial<br />

consequences <strong>of</strong> ill health.<br />

This paper reviews <strong>the</strong> operation <strong>of</strong> exclusion <strong>and</strong> opt <strong>out</strong> policies <strong>in</strong> <strong>the</strong> health sector <strong>in</strong><br />

<strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, <strong>the</strong> only European countries <strong>in</strong> which such policies affect a<br />

significant proportion (more than one per cent) <strong>of</strong> <strong>the</strong> population. In do<strong>in</strong>g so it aims to<br />

illustrate <strong>the</strong> potential impact <strong>of</strong> <strong>in</strong>troduc<strong>in</strong>g exclusion <strong>and</strong> opt <strong>out</strong> policies <strong>in</strong> European health<br />

systems <strong>and</strong> to highlight <strong>the</strong> consequences <strong>of</strong> exclusion <strong>and</strong> opt <strong>out</strong> policies for specific<br />

health system objectives.<br />

After <strong>out</strong>l<strong>in</strong><strong>in</strong>g <strong>the</strong> relationship between statutory <strong>and</strong> substitutive VHI coverage <strong>in</strong> <strong>Germany</strong><br />

<strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, <strong>the</strong> paper reviews <strong>the</strong> consequences <strong>of</strong> allow<strong>in</strong>g some people to choose<br />

between statutory <strong>and</strong> substitutive VHI coverage <strong>and</strong> exam<strong>in</strong>es <strong>the</strong> implications <strong>of</strong> <strong>the</strong> way <strong>in</strong><br />

which private health <strong>in</strong>surers behave <strong>in</strong> a market for substitutive VHI. The paper’s central<br />

argument is that exclusion <strong>and</strong> opt <strong>out</strong> policies do not live up to <strong>the</strong> expectation that <strong>the</strong>y will<br />

stimulate competition between statutory <strong>and</strong> voluntary health <strong>in</strong>surance, nor are <strong>the</strong>y likely to<br />

2


enable governments to conserve public resources for <strong>the</strong> benefit <strong>of</strong> poorer people. Ra<strong>the</strong>r,<br />

<strong>the</strong>se policies conflict with <strong>the</strong> health system objectives <strong>of</strong> equity <strong>in</strong> fund<strong>in</strong>g health care, equity<br />

<strong>of</strong> access to health care, efficiency <strong>and</strong> choice. They also create complexities that precipitate<br />

high levels <strong>of</strong> government <strong>in</strong>tervention <strong>in</strong> areas traditionally free from significant state control.<br />

<strong>Statutory</strong> <strong>and</strong> voluntary health <strong>in</strong>surance <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s<br />

The orig<strong>in</strong>s <strong>of</strong> choice between statutory <strong>and</strong> substitutive VHI coverage <strong>in</strong> <strong>Germany</strong> date back<br />

to <strong>the</strong> establishment <strong>of</strong> compulsory health <strong>in</strong>surance at <strong>the</strong> end <strong>of</strong> <strong>the</strong> n<strong>in</strong>eteenth century. In<br />

1881 <strong>the</strong> chancellor Bismarck attempted to enact legislation for a universal scheme <strong>of</strong><br />

compulsory health <strong>in</strong>surance, but due to heavy political opposition from Liberals <strong>and</strong> Social<br />

Democrats, <strong>the</strong> provisions <strong>of</strong> <strong>the</strong> act that came <strong>in</strong>to force <strong>in</strong> 1883 only established compulsory<br />

enrolment for blue collar workers (Alber 1986; Rosenberg 1986; Katzenste<strong>in</strong> 1987). In 1970 a<br />

new law made enrolment <strong>in</strong> <strong>the</strong> statutory health <strong>in</strong>surance scheme (Gesetzliche<br />

Krankenversicherung; GKV) compulsory for white collar workers with earn<strong>in</strong>gs below an<br />

<strong>in</strong>come threshold (see Table 1). The law also allowed white collar workers with earn<strong>in</strong>gs<br />

above <strong>the</strong> threshold to enrol <strong>in</strong> <strong>the</strong> GKV on a voluntary basis, <strong>the</strong>reby establish<strong>in</strong>g choice<br />

between statutory <strong>and</strong> substitutive VHI coverage for this group. S<strong>in</strong>ce a fur<strong>the</strong>r legislative<br />

change <strong>in</strong> 1989, any employee with earn<strong>in</strong>gs below <strong>the</strong> <strong>in</strong>come threshold, with <strong>the</strong> exception<br />

<strong>of</strong> public sector workers, is compulsorily enrolled <strong>in</strong> <strong>the</strong> GKV, while all those with earn<strong>in</strong>gs<br />

above <strong>the</strong> threshold are permitted to enrol <strong>in</strong> <strong>the</strong> GKV if <strong>the</strong>y so wish.<br />

Employers now <strong>in</strong>form employees when <strong>the</strong>ir gross annual earn<strong>in</strong>gs rise above <strong>the</strong> <strong>in</strong>come<br />

threshold (€45,900 <strong>in</strong> 2003) <strong>and</strong> present <strong>the</strong>m with three options: <strong>the</strong>y can choose not to be<br />

covered by any type <strong>of</strong> health <strong>in</strong>surance; <strong>the</strong>y can purchase substitutive VHI; or <strong>the</strong>y can rejo<strong>in</strong><br />

<strong>the</strong> GKV as voluntary enrolees (Busse 2000). Employees with earn<strong>in</strong>gs above <strong>the</strong> <strong>in</strong>come<br />

threshold <strong>and</strong> <strong>the</strong>ir dependants account for ab<strong>out</strong> 20 per cent <strong>of</strong> <strong>the</strong> population. Three<br />

quarters <strong>of</strong> <strong>the</strong>m choose to rema<strong>in</strong> <strong>in</strong> <strong>the</strong> GKV as voluntary members. The rema<strong>in</strong>der (ab<strong>out</strong><br />

4.5 per cent <strong>of</strong> <strong>the</strong> population) choose to purchase substitutive VHI from one <strong>of</strong> 50 private<br />

health <strong>in</strong>surance companies belong<strong>in</strong>g to <strong>the</strong> German Association <strong>of</strong> Private <strong>Health</strong> Insurers<br />

(Verb<strong>and</strong> der privaten Krankenversicherung; PKV) (PKV 2001). A very small group (0.2 per<br />

cent <strong>of</strong> <strong>the</strong> population) has no health <strong>in</strong>surance coverage at all – ma<strong>in</strong>ly extremely wealthy<br />

people (Busse 2002).<br />

Prior to <strong>the</strong> second world war statutory health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s was entirely<br />

voluntary. A compulsory scheme was established <strong>in</strong> 1941, at <strong>the</strong> <strong>in</strong>stigation <strong>of</strong> <strong>the</strong> occupy<strong>in</strong>g<br />

German forces <strong>and</strong> with disregard for <strong>the</strong> exist<strong>in</strong>g <strong>in</strong>stitutional structures (Blanpa<strong>in</strong> et al. 1978;<br />

3


Cox 1993). The 1941 legislation was largely based on <strong>the</strong> German system, divid<strong>in</strong>g statutory<br />

health <strong>in</strong>surance <strong>in</strong>to two sections: compulsory enrolment for employees <strong>and</strong> <strong>the</strong>ir<br />

dependants <strong>and</strong> voluntary enrolment for self-employed people. The rema<strong>in</strong>der were expected<br />

to purchase private health <strong>in</strong>surance on a voluntary basis. Between 1941 <strong>and</strong> 1965 statutory<br />

coverage was extended to new groups <strong>of</strong> non-employed people. The 1964 Sickness Funds<br />

Act (Ziekenfondswet; ZFW) came <strong>in</strong>to force <strong>in</strong> 1966, establish<strong>in</strong>g <strong>the</strong> system that is <strong>in</strong> place<br />

today. S<strong>in</strong>ce 1966, ab<strong>out</strong> three quarters <strong>of</strong> <strong>the</strong> Dutch population have been covered by <strong>the</strong><br />

ZFW (Organisation for Economic Co-operation <strong>and</strong> Development 2001).<br />

<strong>Health</strong> <strong>in</strong>surance <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s currently operates on three levels (see Table 2) (M<strong>in</strong>istry<br />

<strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport 2002). The first level provides cover for long-term care. Based on<br />

<strong>the</strong> 1967 Exceptional Medical Expenses Act (Algemene Wet Bijzondere Ziektekosten;<br />

AWBZ), it is a universal scheme that is compulsory for all residents.<br />

The second level provides compulsory cover for ‘normal necessary care’, under <strong>the</strong> ZFW, to<br />

employees up to <strong>the</strong> age <strong>of</strong> 65 with gross annual earn<strong>in</strong>gs under <strong>the</strong> <strong>in</strong>come threshold,<br />

residents on benefits <strong>and</strong> (s<strong>in</strong>ce 2000) self-employed people under <strong>the</strong> age <strong>of</strong> 65 with taxable<br />

<strong>in</strong>comes below a lower threshold (see Table 1) (M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport 2002). It<br />

also provides cover on a voluntary basis for members who reach <strong>the</strong> age <strong>of</strong> 65 <strong>and</strong> nonmembers<br />

who are 65 <strong>and</strong> over <strong>and</strong> have a gross annual <strong>in</strong>come below <strong>the</strong> lower threshold.<br />

Individuals with gross annual earn<strong>in</strong>gs above <strong>the</strong> <strong>in</strong>come threshold are no longer eligible for<br />

ZFW coverage, but may purchase substitutive VHI <strong>in</strong>stead. Some civil servants are also<br />

excluded from <strong>the</strong> ZFW. They are covered by a separate statutory health <strong>in</strong>surance scheme<br />

(Publiekrechtelijke ziektekostenverzeker<strong>in</strong>g; PZV), which closely resembles <strong>the</strong> ZFW.<br />

Those that are not eligible for cover under <strong>the</strong> ZFW can purchase substitutive VHI or be<br />

un<strong>in</strong>sured. In 2000 24.7 per cent <strong>of</strong> <strong>the</strong> Dutch population purchased substitutive VHI, down<br />

from 27.2 per cent <strong>in</strong> 1990 (Vektis 2000). Only 1.6 per cent <strong>of</strong> <strong>the</strong> population did not have any<br />

health <strong>in</strong>surance at all; most <strong>of</strong> <strong>the</strong> un<strong>in</strong>sured are homeless <strong>and</strong> a few conscientiously object<br />

to <strong>in</strong>surance (M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport 2000). The <strong>Health</strong> <strong>Insurance</strong> Access Act<br />

(Wet op de Toegang tot Ziektekostenverzeker<strong>in</strong>gen; WTZ) passed <strong>in</strong> 1986 guarantees<br />

substitutive VHI policy holders aged 65 <strong>and</strong> over access to a ‘st<strong>and</strong>ard’ policy that provides a<br />

similar level <strong>of</strong> benefits to <strong>the</strong> ZFW for a fixed premium (see below).<br />

Level three consists <strong>of</strong> complementary <strong>and</strong> supplementary VHI, which can be purchased by<br />

anyone, on a voluntary basis, from sickness funds <strong>and</strong> private <strong>in</strong>surers.<br />

Insert Table 1 here<br />

Insert Table 2 here<br />

4


The health <strong>in</strong>surance options available to different population groups <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s are presented <strong>in</strong> Table 3. In both countries <strong>the</strong> size <strong>of</strong> <strong>the</strong> market for substitutive<br />

VHI is sensitive to developments <strong>in</strong> <strong>the</strong> statutory health <strong>in</strong>surance scheme. Changes <strong>in</strong> <strong>the</strong><br />

benefits provided by statutory coverage are usually followed by changes <strong>in</strong> <strong>the</strong> benefits<br />

provided by substitutive VHI.<br />

Insert Table 3 here<br />

Issues aris<strong>in</strong>g from <strong>the</strong> choice between statutory <strong>and</strong> voluntary health<br />

<strong>in</strong>surance<br />

Allow<strong>in</strong>g certa<strong>in</strong> groups <strong>of</strong> people to opt <strong>out</strong> <strong>of</strong> <strong>the</strong> statutory health <strong>in</strong>surance scheme<br />

presents private health <strong>in</strong>surers with strong <strong>in</strong>centives to persuade low risk <strong>in</strong>dividuals to<br />

leave <strong>the</strong> statutory health <strong>in</strong>surance scheme <strong>and</strong> purchase substitutive VHI. This form <strong>of</strong> risk<br />

selection is made possible by differences <strong>in</strong> <strong>the</strong> way <strong>in</strong> which statutory <strong>and</strong> private health<br />

<strong>in</strong>surers operate, particularly with regard to enrolment, premium-sett<strong>in</strong>g <strong>and</strong> policy conditions.<br />

Those who can obta<strong>in</strong> cheaper coverage from private health <strong>in</strong>surers – ma<strong>in</strong>ly younger<br />

people with no pre-exist<strong>in</strong>g conditions <strong>and</strong> few or no dependants – will leave <strong>the</strong> statutory<br />

health <strong>in</strong>surance scheme. This results <strong>in</strong> self-selection aga<strong>in</strong>st <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme, which closely resembles <strong>the</strong> effects <strong>of</strong> adverse selection <strong>in</strong> <strong>in</strong>surance markets.<br />

Adverse selection arises when <strong>in</strong>surance plans <strong>of</strong>fer<strong>in</strong>g generous benefits are selected by<br />

<strong>in</strong>dividuals with a higher than average risk <strong>of</strong> ill health, caus<strong>in</strong>g <strong>the</strong>se plans to <strong>in</strong>crease<br />

premiums, which <strong>in</strong> turn provokes <strong>in</strong>dividuals with a lower than average risk <strong>of</strong> ill health to<br />

switch to cheaper plans (Cutler <strong>and</strong> Zeckhauser 2000). Ultimately, more generous plans<br />

become f<strong>in</strong>ancially unstable <strong>and</strong> are forced <strong>out</strong> <strong>of</strong> bus<strong>in</strong>ess. Researchers have shown how<br />

adverse selection led to <strong>the</strong> swift collapse <strong>of</strong> <strong>in</strong>demnity <strong>in</strong>surance plans organised by<br />

employers <strong>in</strong> <strong>the</strong> United States (Cutler <strong>and</strong> Zeckhauser 1997).<br />

Where <strong>in</strong>dividuals can choose between statutory <strong>and</strong> VHI coverage, as <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s<br />

prior to 1986 <strong>and</strong> <strong>in</strong> <strong>Germany</strong>, <strong>the</strong> statutory health <strong>in</strong>surance scheme is likely to end up<br />

cover<strong>in</strong>g an adverse selection <strong>of</strong> <strong>the</strong> population – predom<strong>in</strong>antly older people, poorer people,<br />

people with pre-exist<strong>in</strong>g conditions or at higher risk <strong>of</strong> ill health <strong>and</strong> people with dependants.<br />

In order to compensate for <strong>the</strong> loss <strong>of</strong> contributions from low risk – <strong>and</strong> possibly wealthier –<br />

people who have opted <strong>out</strong>, <strong>the</strong> statutory health <strong>in</strong>surance scheme may have to <strong>in</strong>crease<br />

contributions from its rema<strong>in</strong><strong>in</strong>g members. Consequently, <strong>the</strong> public burden <strong>of</strong> fund<strong>in</strong>g health<br />

care falls disproportionately on people with low <strong>in</strong>comes <strong>and</strong> <strong>in</strong> poor health, underm<strong>in</strong><strong>in</strong>g risk<br />

5


<strong>and</strong> <strong>in</strong>come solidarity. The situation is compounded when <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme acts as <strong>the</strong> <strong>in</strong>surer <strong>of</strong> last resort, with people who have previously opted <strong>out</strong> return<strong>in</strong>g<br />

to it when <strong>the</strong>y can no longer afford substitutive VHI premiums.<br />

Faced with self-selection aga<strong>in</strong>st <strong>the</strong> statutory health <strong>in</strong>surance scheme, governments can<br />

respond <strong>in</strong> several ways. First, <strong>the</strong>y can prohibit voluntary exit from <strong>the</strong> statutory health<br />

<strong>in</strong>surance scheme (see Table 3 above), ei<strong>the</strong>r by replac<strong>in</strong>g <strong>the</strong> dual system <strong>of</strong> statutory <strong>and</strong><br />

VHI coverage with a s<strong>in</strong>gle system <strong>of</strong> compulsory health <strong>in</strong>surance or by chang<strong>in</strong>g <strong>the</strong> opt <strong>out</strong><br />

policy to an exclusion policy. Second, <strong>the</strong>y can limit <strong>the</strong> voluntary exit <strong>of</strong> some low risk people<br />

by rais<strong>in</strong>g <strong>the</strong> <strong>in</strong>come threshold or reduce <strong>in</strong>centives to opt <strong>out</strong> by prevent<strong>in</strong>g some or all <strong>of</strong><br />

those who opt <strong>out</strong> from return<strong>in</strong>g. Third, <strong>the</strong>y can compel substitutive VHI policy holders to<br />

subsidise those <strong>in</strong>sured by <strong>the</strong> statutory health <strong>in</strong>surance scheme, ei<strong>the</strong>r explicitly or covertly.<br />

Governments <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s <strong>and</strong> <strong>in</strong> <strong>Germany</strong> adopted some <strong>of</strong> <strong>the</strong>se measures when<br />

<strong>the</strong>y were confronted with self-selection aga<strong>in</strong>st <strong>the</strong> statutory health <strong>in</strong>surance scheme dur<strong>in</strong>g<br />

<strong>the</strong> 1980s <strong>and</strong> 1990s (Wasem 1995).<br />

The <strong>Health</strong> <strong>Insurance</strong> Act passed <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s <strong>in</strong> 1964 (<strong>the</strong> ZFW) established three<br />

separate statutory health <strong>in</strong>surance schemes: a compulsory scheme for employees <strong>and</strong> <strong>the</strong>ir<br />

dependants, a compulsory scheme for older people <strong>and</strong> a voluntary scheme for those not<br />

eligible for cover under <strong>the</strong> compulsory schemes. Eligibility for each <strong>of</strong> <strong>the</strong> schemes was<br />

subject to an <strong>in</strong>come threshold (den Exter et al. 2002). Individuals who were not compulsorily<br />

covered by <strong>the</strong> ZFW could choose between statutory <strong>and</strong> VHI coverage. Initially, most private<br />

health <strong>in</strong>surers rated substitutive VHI premiums on a community basis, so all policy holders<br />

<strong>in</strong>sured by a particular company paid <strong>the</strong> same amount for <strong>the</strong> same level <strong>of</strong> cover. Dur<strong>in</strong>g <strong>the</strong><br />

1970s, however, some <strong>in</strong>surers began to <strong>of</strong>fer discounted premiums for students, to charge<br />

higher premiums for older policy holders, to reject applications <strong>out</strong>right <strong>and</strong> to exclude preexist<strong>in</strong>g<br />

conditions from cover (Gresz et al. 2002b). High risk <strong>in</strong>dividuals were deterred from<br />

leav<strong>in</strong>g <strong>the</strong> statutory health <strong>in</strong>surance scheme by high premiums <strong>and</strong> unfavourable policy<br />

conditions, while low risk <strong>in</strong>dividuals found <strong>the</strong>y were able to obta<strong>in</strong> cheaper coverage from<br />

private <strong>in</strong>surers.<br />

The ensu<strong>in</strong>g exodus <strong>of</strong> younger <strong>and</strong> healthier people from <strong>the</strong> compulsory scheme for older<br />

people <strong>and</strong> <strong>the</strong> voluntary statutory health <strong>in</strong>surance scheme created f<strong>in</strong>ancial difficulties for<br />

<strong>the</strong> ZFW, which faced <strong>in</strong>creas<strong>in</strong>g deficits. In 1986 <strong>the</strong> Dutch government took action to<br />

prevent fur<strong>the</strong>r escalation <strong>of</strong> <strong>the</strong>se deficits. It abolished both schemes, transferr<strong>in</strong>g <strong>the</strong>ir<br />

members to <strong>the</strong> compulsory scheme for employees <strong>and</strong> <strong>the</strong>ir dependants, which was at <strong>the</strong><br />

same time exp<strong>and</strong>ed to cover some people receiv<strong>in</strong>g state benefits (den Exter et al. 2002). In<br />

effect <strong>the</strong> government put an end to <strong>the</strong> opt <strong>out</strong> policy <strong>of</strong> allow<strong>in</strong>g certa<strong>in</strong> <strong>in</strong>dividuals to choose<br />

between statutory <strong>and</strong> VHI coverage, replac<strong>in</strong>g it with <strong>the</strong> exclusion policy that rema<strong>in</strong>s <strong>in</strong><br />

place today.<br />

6


As a result <strong>of</strong> <strong>the</strong> government’s change <strong>of</strong> policy <strong>the</strong> newly-exp<strong>and</strong>ed ZFW found itself<br />

cover<strong>in</strong>g a disproportionately high number <strong>of</strong> elderly people, relative to private <strong>in</strong>surers. The<br />

government <strong>the</strong>refore <strong>in</strong>troduced <strong>the</strong> Act on Jo<strong>in</strong>t Fund<strong>in</strong>g <strong>of</strong> Elderly <strong>Health</strong> <strong>Insurance</strong> Fund<br />

Members (Wet Medef<strong>in</strong>ancier<strong>in</strong>g oververtegenwoordig<strong>in</strong>g Oudere Ziekenfondsverzekerden;<br />

MOOZ), establish<strong>in</strong>g <strong>the</strong> MOOZ, which obliges all substitutive VHI policy holders to make an<br />

annual flat-rate contribution to <strong>the</strong> ZFW. The government also established <strong>the</strong> WTZ (see<br />

above <strong>and</strong> below).<br />

Both <strong>the</strong> MOOZ <strong>and</strong> <strong>the</strong> WTZ are still <strong>in</strong> force today because <strong>the</strong> ZFW cont<strong>in</strong>ues to cover a<br />

disproportionately high number <strong>of</strong> older people (see Table 4). In fact, almost all those aged 65<br />

<strong>and</strong> over who are excluded from <strong>the</strong> ZFW are covered by <strong>the</strong> WTZ, ra<strong>the</strong>r than substitutive<br />

VHI. It is questionable whe<strong>the</strong>r <strong>the</strong> MOOZ has succeeded <strong>in</strong> restor<strong>in</strong>g <strong>the</strong> breach <strong>of</strong> <strong>in</strong>come<br />

<strong>and</strong> risk solidarity caused by <strong>the</strong> opt <strong>out</strong> policy that was <strong>in</strong> place between 1964 <strong>and</strong> 1986.<br />

Annual MOOZ contributions are small, only amount<strong>in</strong>g to ab<strong>out</strong> 5 per cent <strong>of</strong> <strong>the</strong> average<br />

substitutive VHI premium, <strong>and</strong> are unlikely to compensate for <strong>the</strong> low levels <strong>of</strong> <strong>in</strong>come <strong>and</strong><br />

risk solidarity between substitutive VHI <strong>and</strong> <strong>the</strong> ZFW <strong>and</strong> among those who are excluded from<br />

<strong>the</strong> ZFW (Hamilton 1996). Fur<strong>the</strong>rmore, as contributions to <strong>the</strong> ZFW are based on earn<strong>in</strong>gs<br />

ra<strong>the</strong>r than all sources <strong>of</strong> <strong>in</strong>come, substitutive VHI policy holders may <strong>in</strong> fact be subsidis<strong>in</strong>g<br />

some ZFW members who are low earners but have large non-wage <strong>in</strong>comes (Westerh<strong>out</strong><br />

1999).<br />

Insert Table 4 here<br />

The existence <strong>of</strong> an opt <strong>out</strong> policy <strong>in</strong> <strong>Germany</strong> has led to similar issues for <strong>the</strong> statutory health<br />

<strong>in</strong>surance scheme (<strong>the</strong> GKV), although for slightly different reasons. In <strong>the</strong> early 1990s <strong>the</strong><br />

GKV found itself <strong>in</strong> f<strong>in</strong>ancial straits due to <strong>the</strong> fact that it was <strong>in</strong>sur<strong>in</strong>g a disproportionately high<br />

number <strong>of</strong> people with large families, relative to substitutive VHI (Rupprecht et al. 2000).<br />

Because <strong>the</strong> GKV automatically covers its members’ dependants at no extra cost, while<br />

private health <strong>in</strong>surers require policy holders to purchase separate policies for dependants,<br />

family size has always been a critical factor for employees choos<strong>in</strong>g between statutory <strong>and</strong><br />

VHI coverage (Schneider et al. 1992). Clearly, <strong>the</strong> GKV is more attractive to employees with a<br />

higher number <strong>of</strong> dependants. A comparison <strong>of</strong> <strong>the</strong> average annual substitutive VHI premium<br />

(ab<strong>out</strong> DEM 3,500 <strong>in</strong> 1999) <strong>and</strong> <strong>the</strong> average annual maximum GKV contribution (DEM 10,688<br />

overall; DEM 10,805 <strong>in</strong> <strong>the</strong> old Länder <strong>and</strong> DEM 10,570 <strong>in</strong> <strong>the</strong> new Länder) gives some<br />

<strong>in</strong>dication <strong>of</strong> how much a German employee with<strong>out</strong> dependants might save by opt<strong>in</strong>g for<br />

substitutive VHI (Mossialos <strong>and</strong> Thomson 2002). However, an <strong>in</strong>dividual’s actual annual<br />

substitutive VHI premium is likely to be considerably higher than <strong>the</strong> average, as <strong>the</strong> average<br />

also <strong>in</strong>cludes <strong>the</strong> premiums paid by civil servants <strong>and</strong> children, which are substantially lower<br />

than <strong>the</strong> premiums paid by employees <strong>and</strong> self-employed people.<br />

7


At <strong>the</strong> same time <strong>the</strong> GKV came under fur<strong>the</strong>r f<strong>in</strong>ancial pressure caused by an <strong>in</strong>flux <strong>of</strong> older<br />

people who had opted for substitutive VHI when <strong>the</strong>y were younger <strong>and</strong> faced lower<br />

premiums, but could no longer afford to pay <strong>the</strong> premiums dem<strong>and</strong>ed by private health<br />

<strong>in</strong>surers (Wasem 1995). One <strong>of</strong> <strong>the</strong> ways <strong>in</strong> which <strong>the</strong>y were able to do this was by reduc<strong>in</strong>g<br />

<strong>the</strong>ir work<strong>in</strong>g hours prior to retirement, which allowed <strong>the</strong>ir <strong>in</strong>comes to drop below <strong>the</strong><br />

threshold. S<strong>in</strong>ce <strong>the</strong> 1930s substitutive VHI <strong>in</strong> <strong>Germany</strong> has been underwritten <strong>in</strong> <strong>the</strong> same<br />

way as life <strong>in</strong>surance <strong>in</strong> order to protect policy holders. Premiums are loaded to spread costs<br />

over an <strong>in</strong>dividual’s lifetime. Each <strong>in</strong>surer pools premiums for policy holders <strong>in</strong> <strong>the</strong> same age<br />

cohort, <strong>the</strong>reby build<strong>in</strong>g up reserve funds to f<strong>in</strong>ance <strong>the</strong> provision <strong>of</strong> benefits <strong>in</strong> old age.<br />

Insurers are prohibited from term<strong>in</strong>at<strong>in</strong>g contracts, policy holders benefit from lifetime cover<br />

<strong>and</strong> premiums should not, <strong>in</strong> <strong>the</strong>ory, <strong>in</strong>crease as policy holders age. However, an adjustment<br />

clause allows <strong>in</strong>surers to raise premiums if <strong>the</strong>re is any discrepancy between <strong>the</strong> costs used<br />

to calculate premiums <strong>and</strong> <strong>the</strong> actual costs <strong>of</strong> provid<strong>in</strong>g benefits. Dur<strong>in</strong>g <strong>the</strong> 1990s private<br />

health <strong>in</strong>surers used this clause to <strong>in</strong>troduce sharp <strong>in</strong>creases <strong>in</strong> premiums, particularly for<br />

older policy holders. The need to <strong>in</strong>crease premiums stemmed from miscalculation on <strong>the</strong> part<br />

<strong>of</strong> <strong>in</strong>surers ra<strong>the</strong>r than unexpectedly high rates <strong>of</strong> <strong>in</strong>flation ii .<br />

The comb<strong>in</strong>ation <strong>of</strong> a high proportion <strong>of</strong> members with large families <strong>and</strong> <strong>the</strong> return <strong>of</strong> older<br />

people who had not previously contributed to it stretched <strong>the</strong> GKV’s f<strong>in</strong>ances <strong>and</strong> precipitated<br />

a series <strong>of</strong> reforms aimed at restrict<strong>in</strong>g voluntary exit from <strong>the</strong> GKV <strong>and</strong> limit<strong>in</strong>g <strong>the</strong><br />

circumstances under which substitutive VHI policy holders could return to <strong>the</strong> GKV. In 1994<br />

<strong>the</strong> government announced that <strong>the</strong> decision to opt for substitutive VHI would be irreversible<br />

for those aged 65 <strong>and</strong> over (Busse 2000). That is, those who left <strong>the</strong> GKV would not be able<br />

to return to it when <strong>the</strong>y were older, even if <strong>the</strong>ir <strong>in</strong>comes fell below <strong>the</strong> threshold. The Social<br />

<strong>Health</strong> <strong>Insurance</strong> Reform Act <strong>of</strong> 2000 tightened <strong>the</strong> rules fur<strong>the</strong>r by reduc<strong>in</strong>g <strong>the</strong> age<br />

threshold for return<strong>in</strong>g to <strong>the</strong> GKV to 54 (Comité Européen des Assurances 2000). The 2000<br />

Act also addressed <strong>the</strong> problem <strong>of</strong> <strong>in</strong>accurate premium calculations <strong>and</strong> <strong>in</strong>adequate age<strong>in</strong>g<br />

reserves by impos<strong>in</strong>g a surcharge <strong>of</strong> up to 10 per cent <strong>of</strong> <strong>the</strong> gross premium on all new<br />

substitutive VHI policies <strong>and</strong> a premium <strong>in</strong>crease <strong>of</strong> two per cent a year for five years for<br />

exist<strong>in</strong>g policy holders (Datamonitor 2000a). The <strong>in</strong>terest aris<strong>in</strong>g from <strong>the</strong> surcharge is<br />

credited to <strong>the</strong> policy holder <strong>and</strong> used to limit premium <strong>in</strong>creases <strong>in</strong> older age<br />

(Bundesaufsichtsamt für das Versicherungswesen 2001).<br />

Prohibit<strong>in</strong>g substitutive VHI policy holders aged 55 <strong>and</strong> over from return<strong>in</strong>g to <strong>the</strong> GKV is one<br />

way <strong>of</strong> ensur<strong>in</strong>g that GKV contributions do not need to rise to meet <strong>the</strong> cost <strong>of</strong> treat<strong>in</strong>g<br />

<strong>in</strong>dividuals who have not previously contributed to it. But <strong>in</strong> some respects <strong>the</strong> 1994 <strong>and</strong> 2000<br />

reforms may encourage self-selection aga<strong>in</strong>st <strong>the</strong> GKV because those who are risk averse or<br />

who expect to have high levels <strong>of</strong> expenditure on health care <strong>in</strong> <strong>the</strong> future are now less likely<br />

to opt for substitutive VHI. The PKV’s website po<strong>in</strong>ts <strong>out</strong> that substitutive VHI is best value for<br />

8


young <strong>and</strong> healthy people, s<strong>in</strong>gle people <strong>and</strong> double-<strong>in</strong>come couples (PKV 2002b). It also<br />

advises potential policy holders to opt for substitutive VHI as early as possible.<br />

Those purchas<strong>in</strong>g substitutive VHI cont<strong>in</strong>ue to be ma<strong>in</strong>ly young, s<strong>in</strong>gle people or couples with<br />

double <strong>in</strong>comes (Datamonitor 2000a; Datamonitor 2000b). Substitutive VHI policy holders are<br />

also more likely to be adult males liv<strong>in</strong>g <strong>in</strong> <strong>the</strong> old Länder (formerly West <strong>Germany</strong>). In 1999<br />

men accounted for 52.7 per cent <strong>of</strong> those with substitutive VHI, while women only accounted<br />

for 32 per cent <strong>and</strong> children up to <strong>and</strong> <strong>in</strong>clud<strong>in</strong>g 15 years old for 15.3 per cent (PKV 2000).<br />

The low proportion <strong>of</strong> women among those with substitutive VHI may be attributed to <strong>the</strong><br />

lower rate <strong>of</strong> employment for women <strong>and</strong> <strong>the</strong> fact that women have lower earn<strong>in</strong>gs than men<br />

(PKV 2001). Data from 1992 <strong>and</strong> 1993 show that only 4.4 per cent <strong>of</strong> those with substitutive<br />

VHI – <strong>and</strong> 0.8 per cent <strong>of</strong> those with complementary <strong>and</strong> supplementary VHI – were from <strong>the</strong><br />

new Länder (PKV 1994). This discrepancy is still marked; <strong>in</strong> 2001 overall coverage was 11.8<br />

per cent, with 13.5 per cent coverage <strong>in</strong> <strong>the</strong> old Länder compared to only 5.3 per cent<br />

coverage <strong>in</strong> <strong>the</strong> new Länder (Bundesm<strong>in</strong>isterium für Gesundheit 2000; Gesamtverb<strong>and</strong> der<br />

Deutschen Versicherungswirtschaft 2001).<br />

In 2002 <strong>the</strong> government announced its <strong>in</strong>tention to raise <strong>the</strong> <strong>in</strong>come threshold by a higher<br />

than average amount with effect from January 2003 (2002) iii . This has encouraged a larger<br />

than usual exodus from <strong>the</strong> GKV (Fromme <strong>and</strong> Schl<strong>in</strong>gensiepen 2002). While it has not been<br />

possible to obta<strong>in</strong> data ab<strong>out</strong> <strong>the</strong> characteristics <strong>of</strong> those who left <strong>the</strong> GKV between <strong>the</strong> time<br />

<strong>of</strong> <strong>the</strong> announcement <strong>and</strong> January 2003, it is feasible to speculate that most <strong>of</strong> <strong>the</strong>se<br />

<strong>in</strong>dividuals are young <strong>and</strong> <strong>in</strong> good health.<br />

Unlike <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, <strong>the</strong>re are no explicit attempts to transfer resources from<br />

substitutive VHI policy holders to <strong>the</strong> statutory health <strong>in</strong>surance scheme <strong>in</strong> <strong>Germany</strong>.<br />

However, substitutive VHI policy holders may subsidise <strong>the</strong> GKV <strong>in</strong> a less overt way.<br />

Providers are allowed to charge most privately-<strong>in</strong>sured patients 1.7 or 2.3 times <strong>the</strong><br />

reimbursement values – <strong>and</strong> sometimes even more – set <strong>in</strong> <strong>the</strong> fee schedule for private<br />

medical services issued by <strong>the</strong> M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> (Busse 2000). Substitutive VHI policy<br />

holders may <strong>the</strong>refore subsidise <strong>the</strong> GKV through <strong>the</strong> higher fees <strong>the</strong>y pay to providers, which<br />

prevents <strong>in</strong>flation <strong>of</strong> provider costs <strong>in</strong> <strong>the</strong> GKV. At <strong>the</strong> same time, however, providers have a<br />

f<strong>in</strong>ancial <strong>in</strong>centive to treat privately-<strong>in</strong>sured patients before GKV members, although it is not<br />

clear how much this happens <strong>in</strong> practice.<br />

9


Affordability, choice <strong>and</strong> consumer protection <strong>in</strong> <strong>the</strong> market for<br />

substitutive VHI<br />

One <strong>of</strong> <strong>the</strong> arguments <strong>in</strong> favour <strong>of</strong> allow<strong>in</strong>g people to opt <strong>out</strong> <strong>of</strong> <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme <strong>and</strong> purchase substitutive VHI is that it <strong>in</strong>creases choice for consumers. Even where<br />

people are excluded from statutory coverage, it is expected that <strong>the</strong> market for substitutive<br />

VHI will provide <strong>the</strong>m with a greater degree <strong>of</strong> choice, relative to those who are covered by<br />

<strong>the</strong> statutory health <strong>in</strong>surance scheme. However, a closer analysis <strong>of</strong> <strong>the</strong> way <strong>in</strong> which private<br />

<strong>in</strong>surers operate <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s suggests that while substitutive VHI has <strong>the</strong><br />

potential to <strong>of</strong>fer policy holders a superior level <strong>of</strong> choice, <strong>in</strong> practice choices are constra<strong>in</strong>ed<br />

by <strong>in</strong>sufficient levels <strong>of</strong> <strong>in</strong>formation <strong>and</strong> weak protection for consumers. In <strong>the</strong> German case,<br />

<strong>the</strong> wide range <strong>of</strong> options available to employees with earn<strong>in</strong>gs above <strong>the</strong> <strong>in</strong>come threshold<br />

creates complexities that can be difficult for consumers to unravel (Riemer-Hommel et al.<br />

2003). Choices made at a certa<strong>in</strong> po<strong>in</strong>t <strong>in</strong> time may, at a later stage, turn <strong>out</strong> to have been<br />

sub-optimal.<br />

The behaviour <strong>of</strong> private <strong>in</strong>surers may also prevent certa<strong>in</strong> people from obta<strong>in</strong><strong>in</strong>g an<br />

affordable <strong>and</strong> adequate level <strong>of</strong> cover, particularly those with pre-exist<strong>in</strong>g conditions, women,<br />

families <strong>and</strong> older people. This is an issue that can arise <strong>in</strong> any type <strong>of</strong> VHI market, but it is<br />

more likely to be a matter <strong>of</strong> concern to governments when vulnerable people do not have<br />

recourse to alternative sources <strong>of</strong> coverage, for example from <strong>the</strong> state.<br />

Insurers operat<strong>in</strong>g <strong>in</strong> a market for health <strong>in</strong>surance are less likely to be constra<strong>in</strong>ed <strong>in</strong> <strong>the</strong>ir<br />

behaviour than <strong>the</strong>ir statutory counterparts. In general, <strong>the</strong>y do not have to <strong>of</strong>fer open<br />

enrolment, <strong>the</strong>ir premiums are not required to be <strong>in</strong>dependent <strong>of</strong> ability to pay or risk <strong>of</strong> ill<br />

health <strong>and</strong> <strong>the</strong>y can set <strong>the</strong>ir own policy conditions. This is largely true <strong>of</strong> <strong>the</strong> market for<br />

substitutive VHI <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s (see Table 5), although over time private<br />

<strong>in</strong>surers <strong>in</strong> both countries have become subject to a considerable degree <strong>of</strong> government<br />

<strong>in</strong>tervention due to <strong>the</strong> nature <strong>and</strong> size <strong>of</strong> <strong>the</strong> risk <strong>the</strong>y cover.<br />

Insert Table 5 here<br />

Private <strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s are free to reject applications, so some high<br />

risk <strong>in</strong>dividuals may not have access to any form <strong>of</strong> substitutive VHI cover. Pre-exist<strong>in</strong>g<br />

conditions can be excluded <strong>out</strong>right or may be covered if disclosed at <strong>the</strong> time <strong>of</strong> underwrit<strong>in</strong>g,<br />

but at extra cost. As previously noted, substitutive VHI does not automatically extend free<br />

coverage to dependants <strong>in</strong> ei<strong>the</strong>r country, which makes family size a critical factor <strong>in</strong><br />

determ<strong>in</strong><strong>in</strong>g affordability, particularly <strong>in</strong> <strong>Germany</strong>. Dutch families with earn<strong>in</strong>gs above <strong>the</strong><br />

<strong>in</strong>come who obta<strong>in</strong> substitutive VHI through <strong>the</strong>ir employers, on a group basis (see below),<br />

10


may be <strong>in</strong> a more favourable position than those who purchase it <strong>in</strong>dividually, because some<br />

group policies only charge premiums for <strong>the</strong> first two children (E<strong>in</strong>dhoven Technical University<br />

2002).<br />

Substitutive VHI premiums are usually based on <strong>the</strong> actuarial pr<strong>in</strong>ciple <strong>of</strong> risk <strong>and</strong> <strong>the</strong> level <strong>of</strong><br />

cover purchased. The price <strong>of</strong> premiums, <strong>and</strong> <strong>the</strong>ir affordability, <strong>the</strong>refore depends on <strong>the</strong><br />

policy holder’s health status <strong>and</strong> <strong>the</strong> type <strong>of</strong> benefits he or she requires. In <strong>Germany</strong><br />

substitutive VHI premiums are adjusted for age, sex <strong>and</strong> health status. This means that<br />

women pay significantly higher premiums than men. The cost <strong>of</strong> a basic substitutive VHI<br />

policy – that is, with<strong>out</strong> supplementary benefits – is 50 per cent higher for women than for<br />

men <strong>in</strong> <strong>the</strong> 20-30 age group, 42 per cent higher <strong>in</strong> <strong>the</strong> 30-40 age group <strong>and</strong> 30 per cent higher<br />

<strong>in</strong> <strong>the</strong> 40-50 age group (PKV 2002a). These differences <strong>in</strong> price are <strong>in</strong>tended to reflect <strong>the</strong><br />

fact that women are likely to live longer than men <strong>and</strong> may <strong>in</strong>cur additional costs associated<br />

with child birth. Most premiums for substitutive VHI <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s are adjusted for age,<br />

so that a 25 year old <strong>and</strong> a 55 year old buy<strong>in</strong>g a policy for <strong>the</strong> first time will be charged<br />

different rates.<br />

Private <strong>in</strong>surers <strong>in</strong> both countries are required to fund benefits <strong>and</strong> rate premiums for<br />

substitutive VHI <strong>in</strong> such a way as to ensure that <strong>the</strong>y do not <strong>in</strong>crease as policy holders age.<br />

However, as <strong>out</strong>l<strong>in</strong>ed above, this has not prevented private health <strong>in</strong>surers from rais<strong>in</strong>g<br />

premiums substantially. Between 1993 <strong>and</strong> 1999 gross written premiums for substitutive <strong>and</strong><br />

o<strong>the</strong>r types <strong>of</strong> VHI <strong>in</strong> <strong>Germany</strong> grew <strong>in</strong> real terms at a compound annual growth rate <strong>of</strong> 5.2<br />

per cent (PKV 1999) iv . Per capita total expenditure on health care grew at <strong>the</strong> much slower<br />

annual rate <strong>of</strong> 4.5 per cent (calculated <strong>in</strong> national currency units at current prices)<br />

(Organisation for Economic Co-operation <strong>and</strong> Development 2000). S<strong>in</strong>ce 1994 <strong>the</strong> real<br />

compound annual growth <strong>in</strong> premiums for substitutive VHI has been lower, at 2.9 per cent,<br />

compared to a growth rate <strong>of</strong> 8.8 per cent for all o<strong>the</strong>r types <strong>of</strong> VHI (Datamonitor 2000b). This<br />

may be due to <strong>the</strong> fact that many private health <strong>in</strong>surers now subsidise <strong>in</strong>creases <strong>in</strong><br />

substitutive VHI premiums from <strong>the</strong>ir own reserves, <strong>in</strong> order to cont<strong>in</strong>ue to attract new<br />

bus<strong>in</strong>ess, ra<strong>the</strong>r than rais<strong>in</strong>g premiums <strong>and</strong> risk<strong>in</strong>g a repeat <strong>of</strong> <strong>the</strong> adverse publicity that<br />

surrounded <strong>the</strong> market <strong>in</strong> <strong>the</strong> early 1990s, when <strong>the</strong>y were criticised for charg<strong>in</strong>g<br />

unreasonable premiums for older policy holders (Datamonitor 2000b). Some private health<br />

<strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> have been able to exploit a loop hole <strong>in</strong> <strong>the</strong> regulatory framework by<br />

barr<strong>in</strong>g new policy holders from enter<strong>in</strong>g exist<strong>in</strong>g risk pools, which means that those already<br />

<strong>in</strong> those risk pools <strong>in</strong>cur higher premiums because <strong>the</strong>y cannot benefit from <strong>the</strong> entry <strong>of</strong> lower<br />

risk policy holders (Riemer-Hommel et al. 2003).<br />

The sale <strong>of</strong> substitutive VHI policies to groups can also affect price <strong>and</strong> affordability. Private<br />

health <strong>in</strong>surers favour group purchas<strong>in</strong>g because it provides high volumes <strong>of</strong> bus<strong>in</strong>ess with<strong>out</strong><br />

a correspond<strong>in</strong>gly large market <strong>out</strong>lay (BMI Europe 2000) <strong>and</strong> because it means that <strong>the</strong>y<br />

11


cover a younger, healthier <strong>and</strong> more homogenous population (Gauthier et al. 1995). In <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s <strong>the</strong> sale <strong>of</strong> policies to groups – usually large companies – has risen substantially<br />

<strong>in</strong> recent years <strong>and</strong> cont<strong>in</strong>ues to be a rapidly grow<strong>in</strong>g sector <strong>of</strong> <strong>the</strong> substitutive VHI market<br />

(Maarse <strong>and</strong> Paulus 1998). Group-purchased policies now account for over half <strong>of</strong> all<br />

substitutive VHI sales (Vektis 2001). Group policy holders ma<strong>in</strong>ly benefit from m<strong>in</strong>imal risk<br />

rat<strong>in</strong>g – age only – <strong>and</strong> cheaper premiums, but <strong>the</strong>y can also receive additional perks, such<br />

as <strong>the</strong> absence <strong>of</strong> wait<strong>in</strong>g periods, a higher proportion <strong>of</strong> benefits <strong>in</strong> k<strong>in</strong>d, free coverage for<br />

any additional child beyond <strong>the</strong> second <strong>and</strong> priority treatment for employees (ter Meulen <strong>and</strong><br />

van der Made 2000; E<strong>in</strong>dhoven Technical University 2002). If <strong>in</strong>surers are part <strong>of</strong> larger<br />

conglomerates sell<strong>in</strong>g o<strong>the</strong>r types <strong>of</strong> <strong>in</strong>surance, as is <strong>of</strong>ten <strong>the</strong> case <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, group<br />

purchas<strong>in</strong>g provides <strong>the</strong>m with <strong>the</strong> opportunity to market <strong>the</strong>ir o<strong>the</strong>r, more pr<strong>of</strong>itable, products<br />

such as life <strong>in</strong>surance (Schut 2002).<br />

Group-purchased substitutive VHI is not common <strong>in</strong> <strong>Germany</strong>. This is partly due to <strong>the</strong> fact<br />

that employers already contribute to <strong>the</strong> cost <strong>of</strong> <strong>in</strong>dividually-purchased substitutive VHI<br />

policies <strong>and</strong> may <strong>the</strong>refore be reluctant to <strong>in</strong>cur fur<strong>the</strong>r expenses <strong>in</strong> sett<strong>in</strong>g up group<br />

schemes, <strong>and</strong> partly due to <strong>the</strong> small numbers <strong>in</strong>volved (Datamonitor 2000b). In 2000 only<br />

five private <strong>in</strong>surers sold substitutive VHI policies to groups, ma<strong>in</strong>ly mult<strong>in</strong>ational corporations<br />

<strong>and</strong> trades unions (Datamonitor 2000b). Currently, group-purchased policies do not differ<br />

substantially <strong>in</strong> price or content from <strong>in</strong>dividually-purchased policies (Schnitzler 2003b).<br />

In <strong>Germany</strong> <strong>the</strong>re are few differences overall <strong>in</strong> <strong>the</strong> level <strong>of</strong> benefits provided by statutory <strong>and</strong><br />

VHI coverage because <strong>the</strong> GKV cont<strong>in</strong>ues to provide a comprehensive range <strong>of</strong> benefits.<br />

Some private <strong>in</strong>surers may <strong>of</strong>fer a slightly wider range <strong>of</strong> benefits than <strong>the</strong> GKV, particularly<br />

for services such as mammography, pharmaceutical prescriptions <strong>and</strong> expensive dental care,<br />

but <strong>in</strong> o<strong>the</strong>r areas GKV benefits may be more generous than those provided by private health<br />

<strong>in</strong>surers – for example, psycho<strong>the</strong>rapy (Mossialos <strong>and</strong> Thomson 2002). However, a major<br />

dist<strong>in</strong>ction between statutory <strong>and</strong> substitutive VHI coverage is that <strong>the</strong> employee opt<strong>in</strong>g for <strong>the</strong><br />

latter has to purchase more than one policy <strong>in</strong> order to obta<strong>in</strong> a comprehensive package <strong>of</strong><br />

benefits. Private health <strong>in</strong>surers <strong>of</strong>fer <strong>out</strong>patient <strong>and</strong> dental benefits separately from <strong>in</strong>patient<br />

benefits, so while policy holders usually enjoy <strong>the</strong> same benefits as those <strong>in</strong>sured by <strong>the</strong><br />

GKV, <strong>the</strong>ir level <strong>of</strong> cover depends on <strong>the</strong> amount <strong>of</strong> policies <strong>the</strong>y buy (Mossialos <strong>and</strong><br />

Thomson 2002). This may not be problematic where <strong>in</strong>patient care is concerned, as <strong>in</strong>patient<br />

benefits are clearly def<strong>in</strong>ed <strong>and</strong> <strong>the</strong>re is not much variation between <strong>in</strong>patient policies, but<br />

policies <strong>of</strong>fer<strong>in</strong>g <strong>out</strong>patient benefits do vary, particularly with regard to marg<strong>in</strong>al benefits such<br />

as psycho<strong>the</strong>rapy, alternative treatment, rehabilitation <strong>and</strong> transport. Some <strong>out</strong>patient policies<br />

may <strong>the</strong>refore <strong>of</strong>fer lower levels <strong>of</strong> coverage than would be provided by <strong>the</strong> GKV. While<br />

employers contribute up to 50 per cent <strong>of</strong> employees’ substitutive VHI premiums – as <strong>in</strong> <strong>the</strong><br />

GKV – but this contribution is limited to <strong>the</strong> average maximum GKV contribution, so that <strong>the</strong><br />

employee bears <strong>the</strong> full cost <strong>of</strong> any additional benefits purchased (Bundesaufsichtsamt für<br />

12


das Versicherungswesen 2001). Consumer associations <strong>in</strong> <strong>Germany</strong> have recently noted that<br />

<strong>in</strong>dividuals f<strong>in</strong>d it <strong>in</strong>creas<strong>in</strong>gly difficult to dist<strong>in</strong>guish between necessary <strong>and</strong> superfluous VHI<br />

products (Datamonitor 2000b).<br />

Substitutive VHI may present lower-<strong>in</strong>come policy holders with f<strong>in</strong>ancial barriers to access<strong>in</strong>g<br />

health care by provid<strong>in</strong>g benefits <strong>in</strong> cash ra<strong>the</strong>r than <strong>in</strong> k<strong>in</strong>d. Unlike GKV <strong>and</strong> ZFW members,<br />

who receive benefits <strong>in</strong> k<strong>in</strong>d, substitutive VHI policy holders generally have to pay providers<br />

directly <strong>and</strong> are subsequently reimbursed by <strong>the</strong>ir <strong>in</strong>surer. In practice, many private <strong>in</strong>surers <strong>in</strong><br />

<strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s provide some benefits <strong>in</strong> k<strong>in</strong>d, particularly to those with group-purchased<br />

policies. Private <strong>in</strong>surers <strong>in</strong> both countries also <strong>of</strong>fer policy holders a range <strong>of</strong> reimbursement<br />

options <strong>and</strong> different levels <strong>of</strong> cost shar<strong>in</strong>g <strong>in</strong> <strong>the</strong> form <strong>of</strong> deductibles. In <strong>Germany</strong>, for<br />

example, an annual deductible <strong>of</strong> €460 for an <strong>out</strong>patient policy lowers <strong>the</strong> premium to ab<strong>out</strong><br />

70 per cent <strong>of</strong> <strong>the</strong> full price (PKV 2001). However, while deductibles reduce <strong>the</strong> price <strong>of</strong><br />

premiums, <strong>the</strong>y also reduce levels <strong>of</strong> coverage (ter Meulen <strong>and</strong> van der Made 2000).<br />

Prior to reforms that took place <strong>in</strong> both countries dur<strong>in</strong>g <strong>the</strong> 1990s, most people covered by<br />

<strong>the</strong> statutory health <strong>in</strong>surance scheme were not able to choose <strong>the</strong>ir sickness fund (Busse<br />

2000; den Exter et al. 2002). Substitutive VHI <strong>the</strong>refore <strong>of</strong>fered its policy holders a clear<br />

advantage by giv<strong>in</strong>g <strong>the</strong>m choice <strong>of</strong> <strong>in</strong>surer. S<strong>in</strong>ce 1993 <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s <strong>and</strong> 1996 <strong>in</strong><br />

<strong>Germany</strong>, sickness funds have been subject to price competition on <strong>the</strong> basis <strong>of</strong> <strong>the</strong> variable<br />

flat-rate fee (<strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s) v <strong>and</strong> <strong>the</strong> variable contribution rate (<strong>Germany</strong>). The latter can<br />

vary substantially; <strong>in</strong> some regions employees are able to choose between funds with a<br />

contribution rate <strong>of</strong> 11.2 per cent <strong>and</strong> funds with a contribution rate <strong>of</strong> 15 per cent (Gresz et al.<br />

2002a). Estimates <strong>of</strong> <strong>the</strong> share <strong>of</strong> GKV members switch<strong>in</strong>g sickness fund each year range<br />

from three to five per cent (Gresz et al. 2002a) <strong>and</strong> those who switch tend to be young <strong>and</strong><br />

healthy (Busse 2002). In <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s <strong>the</strong> proportion <strong>of</strong> ZFW members switch<strong>in</strong>g is also<br />

low (Schut 2002).<br />

Substitutive VHI policy holders should be able to obta<strong>in</strong> cheaper coverage by switch<strong>in</strong>g to a<br />

different private <strong>in</strong>surer. However, switch<strong>in</strong>g is a costly option for all but <strong>the</strong> youngest <strong>and</strong><br />

most recently <strong>in</strong>sured substitutive VHI policy holders, partly due to <strong>the</strong> way <strong>in</strong> which premiums<br />

are loaded to reflect age at entry <strong>and</strong> partly due to <strong>the</strong> non-transferability <strong>of</strong> age<strong>in</strong>g reserves<br />

<strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> non-transferability <strong>of</strong> claims histories <strong>in</strong> both countries.<br />

In <strong>Germany</strong> age<strong>in</strong>g reserves cannot be transferred from one <strong>in</strong>surer to ano<strong>the</strong>r, <strong>and</strong><br />

premiums are based on age at entry, so <strong>the</strong>re is a strong <strong>in</strong>centive for substitutive VHI policy<br />

holders to stay where <strong>the</strong>y are ra<strong>the</strong>r than mov<strong>in</strong>g to ano<strong>the</strong>r <strong>in</strong>surer <strong>and</strong> pay<strong>in</strong>g a higher<br />

premium. The government’s recent decision to impose a 10 per cent surcharge on all new<br />

policies (see above) makes it even less attractive for policy holders to move to ano<strong>the</strong>r<br />

<strong>in</strong>surer. Switch<strong>in</strong>g <strong>in</strong>surers may not actually be an option for policy holders who suffer from<br />

13


pre-exist<strong>in</strong>g conditions, as <strong>in</strong>surers are able to reject applications. For this reason <strong>the</strong> PKV<br />

warns people not to leave <strong>the</strong>ir current <strong>in</strong>surer until <strong>the</strong>y have been accepted by ano<strong>the</strong>r (PKV<br />

2002b). Even if switch<strong>in</strong>g is an option, cancellation <strong>and</strong> wait<strong>in</strong>g periods may vary between<br />

<strong>in</strong>surers, so policy holders could f<strong>in</strong>d <strong>the</strong>mselves pay<strong>in</strong>g premiums to <strong>the</strong> old <strong>and</strong> new <strong>in</strong>surer<br />

at <strong>the</strong> same time. With <strong>the</strong> exception <strong>of</strong> a small number <strong>of</strong> young policy holders, movement<br />

between private <strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> is marg<strong>in</strong>al (Datamonitor 2000b). Private <strong>in</strong>surers have<br />

recently come under pressure to make age<strong>in</strong>g reserves transferable (Riemer-Hommel et al.<br />

2003), but <strong>the</strong>re is concern ab<strong>out</strong> <strong>the</strong> feasibility <strong>of</strong> this proposal <strong>and</strong> some argue that it would<br />

cause a substantial <strong>in</strong>crease <strong>in</strong> <strong>the</strong> price <strong>of</strong> premiums (Schnitzler 2003a).<br />

Switch<strong>in</strong>g from one private <strong>in</strong>surer to ano<strong>the</strong>r also <strong>in</strong>curs additional costs for most substitutive<br />

VHI policy holders <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s. Because claims histories are not transferable, policy<br />

holders become ‘locked <strong>in</strong>’ to <strong>the</strong>ir exist<strong>in</strong>g policy. Switch<strong>in</strong>g is not a realistic option for older<br />

policy holders or those <strong>in</strong> poor health as a new private health <strong>in</strong>surer would charge <strong>the</strong>m<br />

higher premiums. The ris<strong>in</strong>g prevalence <strong>of</strong> group-purchased substitutive VHI <strong>in</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s means that many employees cannot switch <strong>in</strong>surer unless <strong>the</strong>y move to a<br />

different employer. However, as employers are able to negotiate cheaper premiums <strong>and</strong> more<br />

favourable policy conditions, this restriction <strong>of</strong> choice may not always be to <strong>the</strong> employee’s<br />

disadvantage.<br />

Competition for exist<strong>in</strong>g substitutive VHI policy holders is almost non-existent <strong>in</strong> <strong>Germany</strong> <strong>and</strong><br />

rare <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s (Westerh<strong>out</strong> 1999). Although <strong>the</strong>re is strong competition for new<br />

entrants to <strong>the</strong> market <strong>in</strong> both countries – that is, those who cross <strong>the</strong> <strong>in</strong>come threshold for<br />

<strong>the</strong> first time – this does not always benefit <strong>the</strong> consumer. For example, some private <strong>in</strong>surers<br />

<strong>in</strong> <strong>Germany</strong> deliberately miscalculate entry premiums so that <strong>the</strong>y are able to <strong>of</strong>fer lower rates<br />

than <strong>the</strong>ir competitors, <strong>and</strong> <strong>the</strong>n <strong>in</strong>crease premiums once policy holders are locked <strong>in</strong> <strong>and</strong> no<br />

longer able to switch <strong>in</strong>surer with<strong>out</strong> <strong>in</strong>curr<strong>in</strong>g substantial costs (Riemer-Hommel et al. 2003).<br />

The Dutch market also shows signs <strong>of</strong> strong competition for group-purchased policies,<br />

lead<strong>in</strong>g some private <strong>in</strong>surers to price policies below cost <strong>in</strong> order to <strong>in</strong>crease sales, largely <strong>in</strong><br />

<strong>the</strong> hope <strong>of</strong> be<strong>in</strong>g able to market <strong>the</strong>ir o<strong>the</strong>r <strong>in</strong>surance products to substitutive VHI policy<br />

holders (Schut 2002). Because employers are more active <strong>in</strong> purchas<strong>in</strong>g than <strong>in</strong>dividuals,<br />

<strong>the</strong>re is greater movement between private <strong>in</strong>surers <strong>in</strong> this section <strong>of</strong> <strong>the</strong> market.<br />

Substitutive VHI may <strong>of</strong>fer urban policy holders a wider choice <strong>of</strong> providers <strong>in</strong> <strong>Germany</strong>,<br />

where ab<strong>out</strong> three per cent <strong>of</strong> ambulatory doctors are not contracted by <strong>the</strong> GKV, particularly<br />

if <strong>the</strong>se doctors are concentrated <strong>in</strong> <strong>the</strong> major cities (Busse 2000). It is sometimes claimed<br />

that substitutive VHI policy holders receive higher quality care than GKV members <strong>and</strong><br />

preferential access to treatment – because providers can charge higher prices for privately<strong>in</strong>sured<br />

patients – but this claim has not been substantiated, <strong>and</strong> <strong>in</strong> <strong>the</strong> absence <strong>of</strong> wait<strong>in</strong>g<br />

lists, faster access to health care is unlikely to be an issue (Busse 2001).<br />

14


Dutch substitutive VHI policy holders may also benefit from marg<strong>in</strong>ally greater choice <strong>of</strong><br />

provider. Those covered by <strong>the</strong> ZFW are limited to <strong>the</strong> use <strong>of</strong> providers contracted by <strong>the</strong>ir<br />

sickness fund, although most sickness funds have contracts with most providers <strong>in</strong> <strong>the</strong>ir<br />

region, so this rule does not restrict consumer choice <strong>in</strong> practice (den Exter et al. 2002).<br />

However, substitutive VHI policy holders may have faster access to specialists than ZFW<br />

members as private health <strong>in</strong>surers are less strict than sickness funds <strong>in</strong> enforc<strong>in</strong>g <strong>the</strong> gatekeep<strong>in</strong>g<br />

system <strong>in</strong> place (Kulu-Glasgow et al. 1998). Fur<strong>the</strong>rmore, Dutch providers have a<br />

strong <strong>in</strong>centive to treat substitutive VHI policy holders preferentially to ZFW members<br />

because <strong>the</strong>y are paid on a capitation basis for ZFW patients, but on a fee-for-service basis<br />

for privately-<strong>in</strong>sured patients (ter Meulen <strong>and</strong> van der Made 2000).<br />

In both countries substitutive VHI appears to <strong>of</strong>fer some policy holders advantages <strong>in</strong> terms <strong>of</strong><br />

choice <strong>and</strong> price, relative to statutory coverage. Young <strong>and</strong> healthy employees with no or few<br />

dependants are likely to obta<strong>in</strong> cheaper coverage from private health <strong>in</strong>surers than from <strong>the</strong><br />

statutory health <strong>in</strong>surance scheme, particularly <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, where group-purchased<br />

policies are widely available. However, <strong>the</strong>se advantages may be short-lived. As policy<br />

holders age, premiums tend to <strong>in</strong>crease <strong>and</strong> people become locked <strong>in</strong>, unable to switch to<br />

cheaper policies with<strong>out</strong> <strong>in</strong>curr<strong>in</strong>g substantial costs. The difficulty <strong>of</strong> switch<strong>in</strong>g is compounded<br />

by <strong>in</strong>sufficient access to <strong>in</strong>formation ab<strong>out</strong> alternative options.<br />

Given that eligibility for substitutive VHI is determ<strong>in</strong>ed by <strong>the</strong> level <strong>of</strong> an employee’s earn<strong>in</strong>gs,<br />

<strong>and</strong> those purchas<strong>in</strong>g substitutive VHI are <strong>the</strong>refore relatively high earners, it could be argued<br />

that <strong>the</strong>se issues amount to a matter <strong>of</strong> consumer protection ra<strong>the</strong>r than a problem <strong>of</strong> access<br />

to health care. At <strong>the</strong> same time, policy responses to <strong>the</strong> issue <strong>of</strong> self-selection aga<strong>in</strong>st <strong>the</strong><br />

statutory health <strong>in</strong>surance scheme have led to important changes <strong>in</strong> <strong>the</strong> relationship between<br />

statutory <strong>and</strong> substitutive VHI coverage (see above), so that <strong>the</strong> latter is no longer <strong>the</strong><br />

preserve <strong>of</strong> high earn<strong>in</strong>g employees. The comb<strong>in</strong>ation <strong>of</strong> <strong>the</strong>se regulatory changes with<br />

strong <strong>in</strong>centives for private <strong>in</strong>surers to select low risk <strong>in</strong>dividuals <strong>and</strong> restrict access for high<br />

risk <strong>in</strong>dividuals has transformed what may orig<strong>in</strong>ally have been an issue <strong>of</strong> consumer<br />

protection <strong>in</strong>to an issue <strong>of</strong> social protection. For this reason governments <strong>in</strong> both countries<br />

have been obliged to <strong>in</strong>tervene <strong>in</strong> <strong>the</strong> market for substitutive VHI to ensure that more<br />

vulnerable groups are able to obta<strong>in</strong> an affordable <strong>and</strong> adequate level <strong>of</strong> coverage.<br />

Approaches to protect<strong>in</strong>g <strong>the</strong>se groups <strong>of</strong> people range from m<strong>and</strong>atory risk pool<strong>in</strong>g to<br />

guaranteed levels <strong>of</strong> coverage through st<strong>and</strong>ardised benefits, guaranteed prices, enforced<br />

solidarity payments <strong>and</strong> enforced provision <strong>of</strong> <strong>in</strong>formation.<br />

S<strong>in</strong>ce <strong>the</strong> German government restricted substitutive VHI policy holders’ access to <strong>the</strong> GKV <strong>in</strong><br />

1994 <strong>and</strong> 2000 (see above), private <strong>in</strong>surers have been obliged to <strong>of</strong>fer a ‘st<strong>and</strong>ard tariff’<br />

policy to those aged 55 <strong>and</strong> over who have been privately <strong>in</strong>sured for at least 10 years <strong>and</strong><br />

15


whose <strong>in</strong>comes have fallen below <strong>the</strong> threshold. This type <strong>of</strong> policy guarantees access to <strong>the</strong><br />

same level <strong>of</strong> benefits provided by <strong>the</strong> GKV at a price that cannot exceed <strong>the</strong> average<br />

maximum GKV contribution, or 1.5 times <strong>the</strong> contribution for married couples (Comité<br />

Européen des Assurances 1997; PKV 2001). However, <strong>the</strong> st<strong>and</strong>ard tariff policy fails to put<br />

substitutive VHI policy holders with <strong>in</strong>comes below <strong>the</strong> threshold on an even foot<strong>in</strong>g with GKV<br />

members as it does not cover dependants. Even with <strong>the</strong> 50 per cent reduction for spouses,<br />

<strong>the</strong> st<strong>and</strong>ard tariff policy premium is higher than <strong>the</strong> average maximum GKV contribution.<br />

Initially, few substitutive VHI policy holders switched to a st<strong>and</strong>ard tariff policy – only 1,161<br />

people <strong>in</strong> 1998 <strong>and</strong> 1,407 <strong>in</strong> 1999 – perhaps due to lack <strong>of</strong> <strong>in</strong>formation ab<strong>out</strong> whe<strong>the</strong>r or not<br />

<strong>the</strong>y were eligible to switch (PKV 2000). The 2000 Reform Act addressed this issue by<br />

requir<strong>in</strong>g private health <strong>in</strong>surers to <strong>in</strong>form exist<strong>in</strong>g policy holders <strong>of</strong> <strong>the</strong> possibility <strong>of</strong> switch<strong>in</strong>g<br />

to ano<strong>the</strong>r tariff category when <strong>the</strong>ir premiums go up <strong>and</strong> to advise policy holders aged 60 or<br />

over to switch to a st<strong>and</strong>ard tariff policy or to switch to ano<strong>the</strong>r tariff category that provides <strong>the</strong><br />

same benefits for a lower premium (Bundesaufsichtsamt für das Versicherungswesen 2001).<br />

The Act also stipulates that <strong>in</strong>surers must <strong>in</strong>form potential substitutive VHI policy holders <strong>of</strong><br />

<strong>the</strong> likelihood <strong>of</strong> premiums ris<strong>in</strong>g, <strong>the</strong> possibility <strong>of</strong> limit<strong>in</strong>g <strong>the</strong> rise <strong>in</strong> premiums with old age<br />

<strong>and</strong> <strong>the</strong> irreversibility <strong>of</strong> <strong>the</strong> decision to opt <strong>out</strong> <strong>of</strong> <strong>the</strong> GKV (Comité Européen des Assurances<br />

2000; Bundesaufsichtsamt für das Versicherungswesen 2001). Consequently, <strong>in</strong> 2000 <strong>the</strong><br />

number <strong>of</strong> st<strong>and</strong>ard tariff policy holders more than doubled to 3,024. F<strong>in</strong>ally, <strong>the</strong> Act prevents<br />

providers from charg<strong>in</strong>g more than 1.7 times <strong>the</strong> negotiated fee for st<strong>and</strong>ard tariff policy<br />

holders (Bundesaufsichtsamt für das Versicherungswesen 2001).<br />

Although <strong>the</strong> 2000 Reform Act tried to address concerns ab<strong>out</strong> consumer protection, its<br />

provisions only go so far as to oblige private <strong>in</strong>surers to provide <strong>in</strong>formation ab<strong>out</strong> switch<strong>in</strong>g<br />

tariffs to policy holders aged 60 <strong>and</strong> over, so <strong>in</strong>adequate <strong>in</strong>formation is still an issue for<br />

younger substitutive VHI policy holders, as demonstrated by <strong>the</strong> development <strong>of</strong> a market for<br />

<strong>in</strong>dependent <strong>in</strong>surance brokers <strong>and</strong> websites provid<strong>in</strong>g comparative <strong>in</strong>formation on a nonpr<strong>of</strong>it<br />

basis (see, for example, www.stiftung-warentest.de) <strong>and</strong> <strong>the</strong> proliferation <strong>of</strong> price<br />

comparisons published <strong>in</strong> newspapers <strong>and</strong> magaz<strong>in</strong>es. The PKV has also set up a website<br />

rem<strong>in</strong>d<strong>in</strong>g consumers to leave <strong>the</strong> GKV as soon as possible, not to leave one <strong>in</strong>surer until<br />

<strong>the</strong>y have been accepted by ano<strong>the</strong>r <strong>in</strong>surer, that substitutive VHI does not cover ‘certa<strong>in</strong><br />

th<strong>in</strong>gs’ <strong>and</strong> that substitutive VHI premiums are difficult to ‘check up’ (see www.privatekrankenversicherung.net).<br />

The PKV’s website even advises consumers that substitutive VHI<br />

is best value for young <strong>and</strong> healthy s<strong>in</strong>gle people <strong>and</strong> couples with double <strong>in</strong>comes.<br />

After <strong>the</strong> voluntary ZFW scheme <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s was abolished it became clear that<br />

several groups <strong>of</strong> people who were now forced to rely on substitutive VHI – particularly older<br />

people <strong>and</strong> younger self-employed people with pre-exist<strong>in</strong>g conditions – were f<strong>in</strong>d<strong>in</strong>g it<br />

difficult to cover <strong>the</strong> cost <strong>of</strong> premiums. The Dutch government <strong>the</strong>refore <strong>in</strong>troduced <strong>the</strong> <strong>Health</strong><br />

16


<strong>Insurance</strong> Access Act (Wet op de Toegang tot Ziektekostenverzeker<strong>in</strong>gen; WTZ). This Act<br />

guarantees substitutive VHI policy holders aged 65 <strong>and</strong> over access to a ‘st<strong>and</strong>ard’ policy that<br />

provides a similar level <strong>of</strong> benefits to <strong>the</strong> ZFW for a fixed premium vi . Once substitutive policy<br />

holders reach <strong>the</strong> age <strong>of</strong> 65 <strong>the</strong>ir contracts are term<strong>in</strong>ated <strong>and</strong> <strong>the</strong>y switch to a st<strong>and</strong>ard<br />

policy under <strong>the</strong> WTZ. Substitutive VHI policy holders whose premiums have been higher<br />

than <strong>the</strong> WTZ premium for three consecutive years can also switch to <strong>the</strong> WTZ.<br />

The WTZ premium is more than 20 per cent higher than <strong>the</strong> average ZFW contribution, <strong>and</strong><br />

unlike ZFW cover, a st<strong>and</strong>ard policy does not cover <strong>the</strong> policy holder’s dependants, who must<br />

be separately <strong>in</strong>sured. Ano<strong>the</strong>r essential difference from <strong>the</strong> ZFW is that <strong>the</strong> WTZ provides<br />

benefits <strong>in</strong> cash ra<strong>the</strong>r than k<strong>in</strong>d.<br />

After <strong>the</strong> WTZ was established, it was common for private <strong>in</strong>surers to raise <strong>the</strong> premiums <strong>of</strong><br />

high risk substitutive VHI policy holders to such an extent that <strong>the</strong>se policy holders eventually<br />

became eligible for WTZ cover. Because WTZ premiums only cover half <strong>the</strong> cost <strong>of</strong> <strong>the</strong><br />

benefits <strong>the</strong>y provide, private <strong>in</strong>surers receive full compensation from a central equalisation<br />

fund f<strong>in</strong>anced by annual solidarity contributions from substitutive VHI policy holders. This<br />

contribution amounts to ab<strong>out</strong> 16 per cent <strong>of</strong> <strong>the</strong> average substitutive VHI premium for policy<br />

holders aged under 19 <strong>and</strong> ab<strong>out</strong> 32 per cent for policy holders aged 20 to 64. S<strong>in</strong>ce 1986<br />

substitutive VHI has lost 17 per cent <strong>of</strong> its market share to <strong>the</strong> WTZ (Mossialos <strong>and</strong> Thomson<br />

2002). In 1994 <strong>the</strong> Dutch government curbed private <strong>in</strong>surers’ <strong>in</strong>centives to push non-elderly<br />

high risk <strong>in</strong>dividuals <strong>in</strong>to <strong>the</strong> WTZ by restrict<strong>in</strong>g full compensation to WTZ members aged<br />

under 65.<br />

By <strong>the</strong> early 1990s <strong>the</strong> Dutch government realised that <strong>the</strong> WTZ did not fully remove barriers<br />

to access, but did not take action at that time as it was plann<strong>in</strong>g to reform <strong>the</strong> whole system <strong>of</strong><br />

health <strong>in</strong>surance (den Exter et al. 2002). It was only later, when <strong>the</strong>se plans had been<br />

ab<strong>and</strong>oned, that <strong>the</strong> government <strong>in</strong>troduced fur<strong>the</strong>r measures to protect older people – ma<strong>in</strong>ly<br />

by rais<strong>in</strong>g <strong>the</strong> <strong>in</strong>come threshold, so that more older people were eligible for cover under <strong>the</strong><br />

ZFW vii .<br />

Discussion <strong>and</strong> conclusions<br />

Exclusion <strong>and</strong> opt <strong>out</strong> policies <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s date back to <strong>the</strong> <strong>in</strong>troduction<br />

<strong>of</strong> compulsory health <strong>in</strong>surance for blue-collar workers. Over time <strong>the</strong>y have provided private<br />

<strong>in</strong>surers with strong <strong>in</strong>centives to select low risk <strong>in</strong>dividuals <strong>and</strong> restrict access <strong>and</strong> choice for<br />

high risk <strong>in</strong>dividuals. They have also led to a situation <strong>in</strong> which private <strong>in</strong>surers are able to<br />

shift f<strong>in</strong>ancial risk to o<strong>the</strong>r <strong>in</strong>stitutions. For example, <strong>the</strong> GKV <strong>in</strong> <strong>Germany</strong> acts as <strong>in</strong>surer <strong>of</strong><br />

17


last resort <strong>and</strong> <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s high risk <strong>in</strong>dividuals who are excluded from <strong>the</strong> ZFW can be<br />

covered by <strong>the</strong> WTZ, where <strong>the</strong>ir health care costs are subsidised by non-elderly substitutive<br />

VHI policy holders.<br />

In recent decades governments <strong>in</strong> both countries have <strong>in</strong>tervened heavily <strong>in</strong> <strong>the</strong> market for<br />

substitutive VHI, <strong>in</strong>troduc<strong>in</strong>g reforms to bolster <strong>the</strong> f<strong>in</strong>ances <strong>of</strong> <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme, to ensure access to affordable substitutive cover for vulnerable groups <strong>of</strong> people <strong>and</strong><br />

to <strong>in</strong>crease levels <strong>of</strong> consumer protection. Despite <strong>the</strong>se efforts, <strong>the</strong> complexities created by<br />

<strong>the</strong> existence <strong>of</strong> exclusion <strong>and</strong> opt <strong>out</strong> policies <strong>and</strong> <strong>the</strong> need for successive adjustments<br />

<strong>in</strong>creas<strong>in</strong>gly provoke controversy. Dissatisfaction with <strong>the</strong> current system, comb<strong>in</strong>ed with<br />

concerns ab<strong>out</strong> <strong>the</strong> future susta<strong>in</strong>ability <strong>of</strong> statutory health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> face <strong>of</strong><br />

demographic <strong>and</strong> technological changes, has led to proposals for a radical overhaul <strong>of</strong> health<br />

<strong>in</strong>surance <strong>in</strong> each country.<br />

In 2001 <strong>the</strong> Dutch government announced its <strong>in</strong>tention to ab<strong>and</strong>on <strong>the</strong> policy <strong>of</strong> exclud<strong>in</strong>g<br />

those with <strong>in</strong>comes above <strong>the</strong> threshold from statutory coverage <strong>and</strong> extend ZFW coverage to<br />

<strong>the</strong> whole population (Sheldon 2001; Maarse 2002). However, <strong>the</strong> government was defeated<br />

<strong>in</strong> general elections that took place <strong>the</strong> follow<strong>in</strong>g year. The <strong>in</strong>com<strong>in</strong>g government promised to<br />

<strong>in</strong>troduce a s<strong>in</strong>gle system <strong>of</strong> compulsory health <strong>in</strong>surance for primary <strong>and</strong> acute care<br />

operated by compet<strong>in</strong>g private <strong>in</strong>surers, along <strong>the</strong> l<strong>in</strong>es <strong>of</strong> <strong>the</strong> proposals orig<strong>in</strong>ally mooted by<br />

<strong>the</strong> Dekker Commission <strong>in</strong> <strong>the</strong> late 1980s <strong>and</strong> re-formulated as <strong>the</strong> Simons Plan <strong>in</strong> <strong>the</strong> early<br />

1990s, but this proposal was put on hold by <strong>the</strong> government’s subsequent collapse (Maarse<br />

2002; Hamilton 2003). Key features <strong>of</strong> <strong>the</strong> proposed system <strong>in</strong>cluded open enrolment, flatrate<br />

premiums, tax subsidies to f<strong>in</strong>ance premiums for children, cost shar<strong>in</strong>g <strong>in</strong> <strong>the</strong> form <strong>of</strong> a<br />

m<strong>and</strong>atory m<strong>in</strong>imum deductible <strong>and</strong> risk adjustment between <strong>in</strong>surers.<br />

Reform <strong>of</strong> health <strong>in</strong>surance also played a central role <strong>in</strong> <strong>the</strong> German general election<br />

campaign <strong>in</strong> 2002. Although <strong>the</strong> re-elected government adopted a more moderate approach,<br />

<strong>in</strong>troduc<strong>in</strong>g a reform to restrict people from opt<strong>in</strong>g <strong>out</strong> <strong>of</strong> <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme (see above), debates ab<strong>out</strong> <strong>the</strong> relationship between statutory <strong>and</strong> substitutive VHI<br />

coverage persist <strong>and</strong>, as <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, <strong>the</strong>re have been calls to abolish <strong>the</strong> dual system<br />

<strong>and</strong> replace it with a compulsory system based on competition between private <strong>in</strong>surers<br />

(Henke 2002).<br />

The Dutch proposals for reform <strong>and</strong> policy debates <strong>in</strong> <strong>Germany</strong> share some similarities,<br />

aris<strong>in</strong>g from mutual dissatisfaction with a dual system that is seen to be overly complex <strong>and</strong><br />

subject to perverse <strong>in</strong>centives. The fact that <strong>the</strong>y both opt for compulsory private health<br />

<strong>in</strong>surance may be <strong>in</strong>dicative <strong>of</strong> a belief <strong>in</strong> <strong>the</strong> ability <strong>of</strong> competitive markets to produce<br />

efficiency ga<strong>in</strong>s, but also reflects strong opposition to a universal statutory system from<br />

<strong>in</strong>terest groups such as private <strong>in</strong>surers, civil servants <strong>and</strong> employers.<br />

18


There are several issues to be considered <strong>in</strong> mov<strong>in</strong>g from a statutory system based on<br />

solidarity pr<strong>in</strong>ciples to a compulsory system operated by private <strong>in</strong>surers. In order to facilitate<br />

competition <strong>and</strong> guarantee real choice for all consumers, compulsory private health <strong>in</strong>surance<br />

would have to be accompanied by a robust system <strong>of</strong> risk adjustment between <strong>in</strong>surers,<br />

improved mobility between plans, <strong>in</strong>creased transparency, st<strong>and</strong>ardised benefits <strong>and</strong> better<br />

<strong>in</strong>formation <strong>and</strong> protection for consumers.<br />

Due to <strong>the</strong>ir capacity to avoid or shift f<strong>in</strong>ancial risk, private <strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s currently have limited <strong>in</strong>centives to compete on <strong>the</strong> basis <strong>of</strong> price <strong>and</strong> quality.<br />

Although substitutive VHI does appear to <strong>of</strong>fer advantages for some policy holders, <strong>the</strong><br />

possibility <strong>of</strong> real choice <strong>and</strong> lower prices is <strong>of</strong>ten constra<strong>in</strong>ed by <strong>in</strong>sufficient <strong>in</strong>formation <strong>and</strong><br />

weak consumer protection. While some <strong>of</strong> <strong>the</strong>se issues could be addressed – for example, by<br />

<strong>in</strong>troduc<strong>in</strong>g mechanisms to <strong>in</strong>crease mobility between private <strong>in</strong>surers – o<strong>the</strong>rs might be more<br />

difficult to overcome.<br />

Adequate risk adjustment is expensive to adm<strong>in</strong>ister <strong>and</strong> technically difficult to implement<br />

(Beck <strong>and</strong> Zweifel 1998; Puig-Junoy 1999; van de Ven et al. 2000). Even <strong>the</strong> relatively<br />

sophisticated mechanisms currently applied to sickness funds <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s demonstrate limited predictive power <strong>and</strong> do not sufficiently reduce <strong>in</strong>centives to<br />

select risks (Schut <strong>and</strong> van Doorslaer 1999; Busse 2001). An analysis <strong>of</strong> Dutch sickness<br />

funds’ non-medical expenditure, based on a sample <strong>of</strong> sickness funds, shows that <strong>the</strong>y spend<br />

more than three times as much on selection (€10 per member) as on efficiency measures (€3<br />

per member). Risk selection is likely to present a greater challenge under a system <strong>of</strong><br />

compulsory private <strong>in</strong>surance. When <strong>the</strong> non-medical expenditure <strong>of</strong> sickness funds was<br />

compared to that <strong>of</strong> a sample <strong>of</strong> private <strong>in</strong>surers, <strong>the</strong> latter were found to spend almost three<br />

times as much as <strong>the</strong> former on selection (€28 per <strong>in</strong>sured) <strong>and</strong> ab<strong>out</strong> a third less on<br />

efficiency measures (€2) (Douven <strong>and</strong> Westerh<strong>out</strong> 2000).<br />

Given <strong>the</strong> high adm<strong>in</strong>istrative costs <strong>in</strong>curred by private <strong>in</strong>surers, <strong>in</strong>clud<strong>in</strong>g <strong>the</strong> costs <strong>of</strong><br />

selection, it is questionable whe<strong>the</strong>r a system <strong>of</strong> compulsory private health <strong>in</strong>surance would<br />

succeed <strong>in</strong> deliver<strong>in</strong>g <strong>the</strong> efficiency ga<strong>in</strong>s expected from a competitive market. In 1999<br />

German private <strong>in</strong>surers spent 10.2 per cent <strong>of</strong> <strong>the</strong>ir premium <strong>in</strong>come on adm<strong>in</strong>istration,<br />

compared to 5.09 per cent <strong>in</strong> <strong>the</strong> GKV <strong>in</strong> 2000. Private <strong>in</strong>surers <strong>in</strong>volved <strong>in</strong> substitutive VHI<br />

<strong>and</strong> <strong>the</strong> WTZ <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s also spend a much higher proportion <strong>of</strong> <strong>the</strong>ir total costs on<br />

adm<strong>in</strong>istration (12.7 per cent <strong>in</strong> 1999) than sickness funds <strong>in</strong>volved <strong>in</strong> <strong>the</strong> ZFW (4.4 per cent)<br />

(Vektis 2000).<br />

Fur<strong>the</strong>rmore, private <strong>in</strong>surers <strong>in</strong> both countries have been slow to adopt ‘managed care’<br />

strategies such as vertical <strong>in</strong>tegration, selective contract<strong>in</strong>g or monitor<strong>in</strong>g <strong>of</strong> providers’<br />

19


ehaviour to lower <strong>the</strong>ir unit costs. Until recently private <strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> showed a<br />

reluctance to restrict substitutive VHI policy holders’ choice <strong>of</strong> provider through selective<br />

contract<strong>in</strong>g, partly due to <strong>the</strong> provision <strong>of</strong> cash benefits. Some private <strong>in</strong>surers have <strong>in</strong>vested<br />

<strong>in</strong> <strong>the</strong> establishment <strong>of</strong> provider networks (Datamonitor 2000b: 88). In such situations, <strong>the</strong><br />

compensation for restricted choice for policy holders may be <strong>the</strong> receipt <strong>of</strong> benefits <strong>in</strong> k<strong>in</strong>d<br />

ra<strong>the</strong>r than <strong>in</strong> cash. Managed care is not common among Dutch private <strong>in</strong>surers ei<strong>the</strong>r,<br />

largely because <strong>the</strong> substitutive VHI market is fragmented <strong>and</strong> providers tend to be wellorganised,<br />

result<strong>in</strong>g <strong>in</strong> poor barga<strong>in</strong><strong>in</strong>g power for <strong>in</strong>surers (Westerh<strong>out</strong> 1999), but also due to<br />

<strong>the</strong> difficulty <strong>of</strong> obta<strong>in</strong><strong>in</strong>g licences to open cl<strong>in</strong>ics or hospitals <strong>and</strong> o<strong>the</strong>r regulatory restrictions<br />

(Schut 1995; Schut 2002).<br />

Go<strong>in</strong>g beyond technical issues, some analysts have suggested that a system <strong>of</strong> private health<br />

<strong>in</strong>surance with<strong>in</strong> <strong>the</strong> European Union would be subject both to competition law <strong>and</strong> to<br />

legislation on <strong>the</strong> s<strong>in</strong>gle market, particularly as <strong>the</strong> European Commission’s Third non-life<br />

<strong>in</strong>surance directive applies to health <strong>in</strong>surance (European Communities 1992; Raad voor de<br />

Volksgezondheid en Zorg 2000; Palm 2001; Hamilton 2003). This might have negative<br />

consequences for health policy objectives such as accessibility <strong>and</strong> solidarity. Discussion<br />

ab<strong>out</strong> compatibility with EU law has played a key role <strong>in</strong> <strong>the</strong> Dutch context, <strong>in</strong>fluenc<strong>in</strong>g <strong>the</strong><br />

government’s 2001 decision to extend <strong>the</strong> ZFW.<br />

Analysis <strong>of</strong> <strong>the</strong> way <strong>in</strong> which private <strong>in</strong>surers <strong>of</strong>fer<strong>in</strong>g substitutive VHI operate <strong>in</strong> <strong>Germany</strong> <strong>and</strong><br />

<strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s raises serious questions ab<strong>out</strong> <strong>the</strong> equity <strong>and</strong> efficiency implications <strong>of</strong><br />

mov<strong>in</strong>g to a system <strong>of</strong> compulsory private health <strong>in</strong>surance. Although <strong>the</strong> dual existence <strong>of</strong><br />

statutory <strong>and</strong> substitutive VHI results <strong>in</strong> <strong>in</strong>efficiencies <strong>and</strong> may <strong>in</strong>flate costs <strong>in</strong> <strong>the</strong> health<br />

system as a whole, replac<strong>in</strong>g <strong>the</strong> current system with compulsory private health <strong>in</strong>surance is<br />

unlikely fully to address exist<strong>in</strong>g concerns <strong>and</strong> may give rise to fur<strong>the</strong>r challenges.<br />

20


Tables<br />

Table 1 <strong>Statutory</strong> health <strong>in</strong>surance <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, 2002<br />

<strong>Germany</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s<br />

<strong>Statutory</strong> coverage (% population) GKV compulsory 75%<br />

GKV voluntary 13%<br />

LTC 100%<br />

Employee contributions (% <strong>of</strong> gross<br />

earn<strong>in</strong>gs)<br />

Employer contributions (% <strong>of</strong><br />

employee’s gross earn<strong>in</strong>gs)<br />

variable; average 6.75% <strong>of</strong><br />

gross earn<strong>in</strong>gs<br />

variable; average 6.75% <strong>of</strong><br />

employee’s gross earn<strong>in</strong>gs<br />

Annual <strong>in</strong>come threshold €45,900 (raised from €41,400<br />

<strong>in</strong> 2003)<br />

AWBZ 100%<br />

ZFW 65%<br />

1.70% (ZFW)<br />

10.25% (AWBZ)<br />

6.25% (ZFW)<br />

0% (AWBZ)<br />

€30,700 (ZFW)<br />

Source: Authors’ estimates based on MISSOC 2003, Busse 2000 <strong>and</strong> den Exter 2002<br />

21


Table 2 Different levels <strong>of</strong> health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, 2000<br />

Type <strong>of</strong> care Scheme Insurers %<br />

covered<br />

Type %<br />

TEH<br />

First level 44%<br />

Long-term care<br />

Mental health care<br />

Care for disabled<br />

people<br />

AWBZ<br />

Sickness funds<br />

<strong>and</strong> private<br />

<strong>in</strong>surers<br />

100.0 Compulsory<br />

Second level 53%<br />

Outpatient <strong>and</strong> ZFW Sickness funds 64.6 Compulsory<br />

<strong>in</strong>patient care<br />

Substitutive VHI Private <strong>in</strong>surers 24.7 Voluntary<br />

WTZ* Private <strong>in</strong>surers 4.2 Voluntary<br />

PZV** Sickness funds 4.9 Compulsory<br />

Un<strong>in</strong>sured - 1.6 -<br />

Third level 3%<br />

O<strong>the</strong>r Complementary /<br />

Supplementary<br />

VHI<br />

Sickness funds<br />

<strong>and</strong> private<br />

<strong>in</strong>surers<br />

Source: Authors’ estimates based on Vektis 2000 <strong>and</strong> den Exter 2002<br />

TEH: total expenditure on health care<br />

* WTZ: scheme created by <strong>the</strong> 1986 <strong>Health</strong> <strong>Insurance</strong> Access Act<br />

** PZV: scheme for civil servants<br />

60.0 Voluntary<br />

22


Table 3 <strong>Health</strong> <strong>in</strong>surance options <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, 2002<br />

<strong>Germany</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s<br />

People with earn<strong>in</strong>gs / <strong>in</strong>comes under <strong>the</strong> threshold<br />

Employees <strong>and</strong> <strong>the</strong>ir<br />

Compulsory GKV members Compulsory ZFW members<br />

dependants<br />

Self-employed<br />

Excluded from <strong>the</strong> GKV unless Compulsory ZFW members<br />

<strong>the</strong>y have been members<br />

previously<br />

Aged 65+ Compulsory GKV members Voluntary ZFW members<br />

Voluntary exit from <strong>the</strong> ZFW<br />

People with earn<strong>in</strong>gs / <strong>in</strong>comes above <strong>the</strong> threshold<br />

Employees <strong>and</strong> <strong>the</strong>ir<br />

Voluntary GKV members Excluded from <strong>the</strong> ZFW<br />

dependants<br />

Voluntary exit from <strong>the</strong> GKV<br />

Self-employed<br />

Excluded from <strong>the</strong> GKV unless Excluded from <strong>the</strong> ZFW<br />

<strong>the</strong>y have been members<br />

previously<br />

Aged 65+<br />

Voluntary GKV members<br />

Voluntary exit from <strong>the</strong> GKV<br />

Voluntary ZFW members<br />

Voluntary exit from <strong>the</strong> ZFW<br />

O<strong>the</strong>r groups<br />

Civil servants Excluded from <strong>the</strong> GKV Compulsory PZV members<br />

Substitutive VHI policy holders<br />

aged < 65<br />

Substitutive VHI policy holders<br />

aged 65+<br />

Entry to <strong>the</strong> GKV only if <strong>the</strong>y are<br />

< 55 <strong>and</strong> <strong>the</strong>ir <strong>in</strong>comes fall<br />

below <strong>the</strong> threshold<br />

No entry to <strong>the</strong> GKV for those<br />

aged 55+<br />

Entry to <strong>the</strong> WTZ only if <strong>the</strong>ir<br />

premiums are higher than <strong>the</strong><br />

maximum for <strong>the</strong>ir age group<br />

<strong>and</strong> <strong>the</strong>y have been privately<br />

<strong>in</strong>sured for at least 3 years<br />

Compulsory exit from<br />

substitutive VHI<br />

Voluntary entry to <strong>the</strong> WTZ<br />

Source: Authors’ estimates based on Busse 2000 <strong>and</strong> den Exter 2002<br />

Note: Where people can voluntarily exit <strong>the</strong> GKV or ZFW, <strong>the</strong>y can purchase substitutive VHI<br />

or be un<strong>in</strong>sured.<br />

23


Table 4 Age distribution <strong>in</strong> <strong>the</strong> Dutch population, <strong>the</strong> ZFW, substitutive VHI <strong>and</strong> <strong>the</strong><br />

WTZ <strong>in</strong> 2000<br />

Age % Population % ZFW % Substitutive<br />

VHI <strong>and</strong> WTZ<br />

0-19 24.4 21.3 30.9<br />

20-64 62.0 63.4 59.0<br />

65+ 13.6 15.2 10.1<br />

Total 100.0 100.0 100.0<br />

Source: Vektis 2000<br />

24


Table 5 Aspects <strong>of</strong> substitutive VHI market conduct <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s<br />

<strong>Germany</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s<br />

Open enrolment No No<br />

Can <strong>in</strong>surers reject Yes<br />

Yes<br />

applications?<br />

Pre-exist<strong>in</strong>g conditions Excluded if known at time <strong>of</strong><br />

underwrit<strong>in</strong>g <strong>and</strong> not disclosed;<br />

covered for a higher premium if<br />

declared<br />

Can be excluded or covered for a<br />

higher premium<br />

Premium rat<strong>in</strong>g Risk rat<strong>in</strong>g (age, sex, health status) Risk rat<strong>in</strong>g (age)<br />

Dependants covered? Must purchase separate policy Must purchase separate policy<br />

Employer contribution Up to 50% up to GKV average<br />

maximum contribution; only to<br />

specialist <strong>in</strong>surers<br />

No<br />

Can <strong>in</strong>surers term<strong>in</strong>ate<br />

policy?<br />

No<br />

No; but policies automatically<br />

term<strong>in</strong>ated at age 65 with move to<br />

<strong>the</strong> WTZ<br />

Cover Lifetime Annual<br />

Fund<strong>in</strong>g system Capital: non-transferable age<strong>in</strong>g Pay as you go: pool<strong>in</strong>g by age group<br />

reserves<br />

Sales to groups (%<br />

total sales)<br />

Choice <strong>of</strong> <strong>in</strong>surer<br />

6.5% 34.5% <strong>in</strong> 1980; 53.8% <strong>in</strong> 1998 <strong>and</strong><br />

55.9% <strong>in</strong> 2001<br />

Yes; but <strong>in</strong> practice limited to new<br />

entrants<br />

Choice <strong>of</strong> benefits Yes Yes<br />

St<strong>and</strong>ard package<br />

required by law<br />

Benefits <strong>in</strong> cash or <strong>in</strong><br />

k<strong>in</strong>d?<br />

No; benefits similar to GKV, but wide<br />

variations at <strong>the</strong> marg<strong>in</strong><br />

Insured are ma<strong>in</strong>ly reimbursed;<br />

some benefits <strong>in</strong> k<strong>in</strong>d<br />

Yes; but <strong>in</strong> practice limited to new<br />

entrants<br />

No; benefits similar to ZFW, but<br />

variations at <strong>the</strong> marg<strong>in</strong><br />

Insured are ma<strong>in</strong>ly reimbursed;<br />

some benefits <strong>in</strong> k<strong>in</strong>d<br />

Cost shar<strong>in</strong>g Yes; usually deductibles Yes; usually deductibles<br />

Sources: Authors’ estimates based on various sources<br />

25


References<br />

Alber, J. (1986). <strong>Germany</strong>. In Growth to limits: <strong>the</strong> western European welfare states s<strong>in</strong>ce<br />

World War II. P. Flora, Ed. Berl<strong>in</strong>, Walter de Gruyter.<br />

Anonymous (2002). [Erst ab 5.100 Euro zu den Privaten], 17 October 2002. Süddeutsche<br />

Zeitung. Munich.<br />

Barr, N. (1992). 'Economic <strong>the</strong>ory <strong>and</strong> <strong>the</strong> welfare state: a survey <strong>and</strong> <strong>in</strong>terpretation.' Journal<br />

<strong>of</strong> Economic Literature 30: 741-803.<br />

Beck, K. <strong>and</strong> P. Zweifel (1998). 'Cream-skimm<strong>in</strong>g <strong>in</strong> deregulated social health <strong>in</strong>surance:<br />

evidence from Switzerl<strong>and</strong>.' Dev <strong>Health</strong> Econ Public Policy 6: 211-27.<br />

Blackwell, N. <strong>and</strong> D. Kruger (2002). Better healthcare for all: replac<strong>in</strong>g <strong>the</strong> NHS monopoly,<br />

The <strong>in</strong>itial report <strong>of</strong> <strong>the</strong> CPS <strong>Health</strong> Policy Group. London, Centre for Policy Studies.<br />

Blanpa<strong>in</strong>, J., L. Delesie <strong>and</strong> H. Nys (1978). National health <strong>in</strong>surance <strong>and</strong> health resources:<br />

<strong>the</strong> European experience. Cambridge, Massachusetts, Harvard University Press.<br />

BMI Europe (2000). Medical <strong>in</strong>surance, http://www.bmieurope.com/cover/medical.html. 2000.<br />

Bundesaufsichtsamt für das Versicherungswesen (2001). Unpublished submission to <strong>the</strong><br />

report on voluntary health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> European Union prepared for <strong>the</strong><br />

Directorate General for Employment <strong>and</strong> Social Affairs <strong>of</strong> <strong>the</strong> European Commission.<br />

Berl<strong>in</strong>, Bundesaufsichtsamt für das Versicherungswesen.<br />

Bundesm<strong>in</strong>isterium für Gesundheit (2000). Statistisches Taschenbuch Gesundheit 2000.<br />

Bonn, Bundesm<strong>in</strong>isterium für Gesundheit.<br />

Busse, R. (2000). <strong>Health</strong> care systems <strong>in</strong> transition: <strong>Germany</strong>. Copenhagen, European<br />

Observatory on <strong>Health</strong> Care Systems.<br />

Busse, R. (2001). 'Risk structure compensation <strong>in</strong> <strong>Germany</strong>'s statutory health <strong>in</strong>surance.'<br />

European Journal <strong>of</strong> Public <strong>Health</strong> 11(2): 174-177.<br />

Busse, R. (2002). <strong>Germany</strong>. In <strong>Health</strong> care systems <strong>in</strong> eight countries: trends <strong>and</strong> challenges.<br />

Report commissioned by <strong>the</strong> <strong>Health</strong> Trends Review, HM Treasury. A. Dixon <strong>and</strong> E.<br />

Mossialos, Eds. London, European Observatory on <strong>Health</strong> Care Systems.<br />

Comité Européen des Assurances (1997). <strong>Health</strong> <strong>Insurance</strong> <strong>in</strong> Europe 1997. Paris, CEA.<br />

Comité Européen des Assurances (2000). <strong>Health</strong> <strong>in</strong>surance <strong>in</strong> Europe: 1998 data, CEA ECO<br />

12 (July 2000). Paris, CEA.<br />

Cox, R. H. (1993). The development <strong>of</strong> <strong>the</strong> Dutch welfare state: from workers' <strong>in</strong>surance to<br />

universal entitlement. Pittsburgh, University <strong>of</strong> Pittsburgh Press.<br />

Cutler, D. <strong>and</strong> R. J. Zeckhauser (2000). The anatomy <strong>of</strong> health <strong>in</strong>surance. In H<strong>and</strong>book <strong>of</strong><br />

health economics, Volume 1A. A. Culyer <strong>and</strong> J. P. Newhouse, Eds. Amsterdam,<br />

Elsevier Science.<br />

Cutler, D. M. <strong>and</strong> R. J. Zeckhauser (1997). Adverse selection <strong>in</strong> health <strong>in</strong>surance, NBER<br />

Work<strong>in</strong>g Paper 6107. Cambridge, National Bureau <strong>of</strong> Economic Research.<br />

26


Datamonitor (2000a). European health <strong>in</strong>surance 2000: what's <strong>the</strong> prognosis, doctor?<br />

London, Datamonitor.<br />

Datamonitor (2000b). Long term care <strong>and</strong> health <strong>in</strong>surance <strong>in</strong> <strong>Germany</strong> 2000: car<strong>in</strong>g for <strong>the</strong><br />

future? London, Datamonitor.<br />

den Exter, A., H. E. Hermans <strong>and</strong> M. Dosljak (2002). <strong>Health</strong> care systems <strong>in</strong> transition:<br />

Ne<strong>the</strong>rl<strong>and</strong>s. Copenhagen, European Observatory on <strong>Health</strong> Care Systems.<br />

Douven, R. <strong>and</strong> E. Westerh<strong>out</strong> (2000). 'Reimbursement systems <strong>in</strong> Dutch sickness funds.'<br />

CPB Report 2000(3): 51-55.<br />

E<strong>in</strong>dhoven Technical University (2002). The group health <strong>in</strong>surance <strong>of</strong> VGZ,<br />

http://www.tue.nl/dpo/sjablonen/9902883%20VGZ-Brochure%20Engels.pdf, access<br />

date 30 July 2002. E<strong>in</strong>dhoven, E<strong>in</strong>dhoven Technical University.<br />

European Communities (1992). 'Council Directive 92/49/EEC <strong>of</strong> 18 June 1992 on <strong>the</strong><br />

coord<strong>in</strong>ation <strong>of</strong> laws, regulations <strong>and</strong> adm<strong>in</strong>istrative provisions relat<strong>in</strong>g to direct<br />

<strong>in</strong>surance o<strong>the</strong>r than life assurance <strong>and</strong> amend<strong>in</strong>g Directives 73/239/EEC <strong>and</strong><br />

88/357/EEC (Third non-life <strong>in</strong>surance directive).' OJEC L 228(11 August 1992): 1-23.<br />

Fromme, H. <strong>and</strong> I. Schl<strong>in</strong>gensiepen (2002). [Privater Krankenschutz wird teurer], 7 August<br />

2002. F<strong>in</strong>ancial Times Deutschl<strong>and</strong>. Hamburg.<br />

Gauthier, A., J. Lamphere <strong>and</strong> N. Barr<strong>and</strong> (1995). 'Risk selection <strong>in</strong> <strong>the</strong> health care market: a<br />

workshop overview.' Inquiry 32: 14-22.<br />

Gesamtverb<strong>and</strong> der Deutschen Versicherungswirtschaft (2001). The German <strong>in</strong>surance<br />

<strong>in</strong>dustry: 2001 yearbook. Berl<strong>in</strong>, Gesamtverb<strong>and</strong> der Deutschen<br />

Versicherungswirtschaft e. V.<br />

Gresz, S., P. Groenewegen, J. Kerssens, B. Braun <strong>and</strong> J. Wasem (2002a). 'Free choice <strong>of</strong><br />

sickness fund <strong>in</strong> regulated competition: evidence from <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s.' <strong>Health</strong> Policy 60: 235-254.<br />

Gresz, S., K. Okma <strong>and</strong> J. Wasem (2002b). Private health <strong>in</strong>surance <strong>in</strong> social health<br />

<strong>in</strong>surance countries: market <strong>out</strong>comes <strong>and</strong> policy implications, Discussion Paper<br />

01/2002. Greifswald, Ernst-Moritz-Arndt Universität Greifswald.<br />

Hamilton, G. J. (1996). 'Changes <strong>in</strong> <strong>the</strong> health <strong>in</strong>surance system <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s.'<br />

European Journal <strong>of</strong> <strong>Health</strong> Law 3: 359-371.<br />

Hamilton, G. J. (2003). 'Private <strong>in</strong>surance for all <strong>in</strong> <strong>the</strong> Dutch health care system?' European<br />

Journal <strong>of</strong> <strong>Health</strong> Law 10(1): 53-61.<br />

Henke, K.-D. (2002). 'The permanent crisis <strong>in</strong> German healthcare.' Eurohealth 8(2): 26-28.<br />

Howard, M. (2003). Reform <strong>of</strong> <strong>the</strong> public services: <strong>the</strong> boundary between <strong>the</strong> private <strong>and</strong><br />

public sectors, Lecture given to <strong>the</strong> Centre for Policy Studies on 24 March 2003.<br />

London, Centre for Policy Studies.<br />

Katzenste<strong>in</strong>, P. J. (1987). Policy <strong>and</strong> politics <strong>in</strong> West <strong>Germany</strong>: <strong>the</strong> growth <strong>of</strong> a semisovereign<br />

state. Philadelphia, Temple University Press.<br />

Kulu-Glasgow, I., D. Delnoij <strong>and</strong> D. de Bakker (1998). 'Self-referral <strong>in</strong> a gatekeep<strong>in</strong>g system:<br />

patients' reasons for skipp<strong>in</strong>g <strong>the</strong> general practitioner.' <strong>Health</strong> Policy 45: 221-23.<br />

27


Maarse, H. (2002). '<strong>Health</strong> <strong>in</strong>surance reform (aga<strong>in</strong>) <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s: will it succeed?' Euro<br />

Observer 4(3): 1-3.<br />

Maarse, H. <strong>and</strong> A. Paulus (1998). <strong>Health</strong> <strong>in</strong>surance reforms <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, Belgium <strong>and</strong><br />

<strong>Germany</strong>: a comparative analysis. In <strong>Health</strong> care <strong>and</strong> its f<strong>in</strong>anc<strong>in</strong>g <strong>in</strong> <strong>the</strong> s<strong>in</strong>gle<br />

European market. R. Leidl, Ed. Oxford, IOS Press: 230-53.<br />

M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport (2000). Personal communication with <strong>the</strong> M<strong>in</strong>istry's<br />

Public Information Office.<br />

M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport (2002). <strong>Health</strong> <strong>in</strong>surance <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s: status as <strong>of</strong><br />

1 January 2002. The Hague, M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong>, Welfare <strong>and</strong> Sport.<br />

Mossialos, E. <strong>and</strong> S. Thomson (2002). Voluntary health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> European Union:<br />

report prepared for <strong>the</strong> Directorate General for Employment <strong>and</strong> Social Affairs <strong>of</strong> <strong>the</strong><br />

European Commission, available onl<strong>in</strong>e at:<br />

http://europa.eu.<strong>in</strong>t/comm/employment_social/soc-prot/social/<strong>in</strong>dex_en.htm. London,<br />

London School <strong>of</strong> Economics <strong>and</strong> Political Science.<br />

Organisation for Economic Co-operation <strong>and</strong> Development (2000). <strong>Health</strong> Data 2000. Paris,<br />

Organisation for Economic Co-operation <strong>and</strong> Development.<br />

Organisation for Economic Co-operation <strong>and</strong> Development (2001). <strong>Health</strong> Data 2001. Paris,<br />

Organisation for Economic Co-operation <strong>and</strong> Development.<br />

Organisation for Economic Co-operation <strong>and</strong> Development (2002). <strong>Health</strong> Data 2002. Paris,<br />

Organisation for Economic Co-operation <strong>and</strong> Development.<br />

Palm, W. (2001). Voluntary health <strong>in</strong>surance <strong>and</strong> EU <strong>in</strong>surance directives: between solidarity<br />

<strong>and</strong> <strong>the</strong> market. Brussels, Association Internationale de la Mutualité.<br />

PKV (1994). Private health <strong>in</strong>surance: facts <strong>and</strong> figures 1992/93. Köln, Verb<strong>and</strong> der privaten<br />

Krankenversicherung e.V.<br />

PKV (1999). Private health <strong>in</strong>surance: facts <strong>and</strong> figures 1998/1999, available onl<strong>in</strong>e at:<br />

http://www.pkv.de/default.asp. Köln, Verb<strong>and</strong> der privaten Krankenversicherung e.V.<br />

PKV (2000). Private health <strong>in</strong>surance: facts <strong>and</strong> figures 1999/2000, available onl<strong>in</strong>e at:<br />

http://www.pkv.de/default.asp. Köln, Verb<strong>and</strong> der privaten Krankenversicherung e.V.<br />

PKV (2001). Private health <strong>in</strong>surance: facts <strong>and</strong> figures 2000/2001, available onl<strong>in</strong>e at:<br />

http://www.pkv.de/default.asp. Köln, Verb<strong>and</strong> der privaten Krankenversicherung e.V.<br />

PKV (2002a). e-PKV, www.e-pkv.de. 2002.<br />

PKV (2002b). Private-Krankenversicherung.net, http://www.privatekrankenversicherung.net/<strong>in</strong>dex.htm.<br />

2002.<br />

Puig-Junoy, J. (1999). 'Manag<strong>in</strong>g risk selection <strong>in</strong>centives <strong>in</strong> health sector reforms.'<br />

International Journal <strong>of</strong> <strong>Health</strong> Plann<strong>in</strong>g <strong>and</strong> Management 14: 287-311.<br />

Raad voor de Volksgezondheid en Zorg (2000). Europe <strong>and</strong> healthcare, 11 January 2000,<br />

http://www.rvz.net/Samenvat/Werk99/europe.htm. 2000.<br />

Riemer-Hommel, P., U. Hommel, A. Kemper <strong>and</strong> H. Farag (2003). Regulat<strong>in</strong>g <strong>the</strong> choice<br />

between public <strong>and</strong> private coverage: an option-based analysis <strong>of</strong> <strong>the</strong> German health<br />

<strong>in</strong>surance system, Work<strong>in</strong>g Paper. Trier, University <strong>of</strong> Trier.<br />

28


Rosenberg, P. (1986). The orig<strong>in</strong> <strong>and</strong> <strong>the</strong> development <strong>of</strong> compulsory health <strong>in</strong>surance <strong>in</strong><br />

<strong>Germany</strong>. In Political values <strong>and</strong> health care: <strong>the</strong> German experience. D. Light <strong>and</strong> A.<br />

Schuller, Eds. Cambridge, Massachusetts, The MIT Press.<br />

Rupprecht, F., B. Tissot <strong>and</strong> F. Chatel (2000). 'German health care system: promot<strong>in</strong>g greater<br />

responsibility among all system players.' INSEE Studies 42(January 2000).<br />

Schneider, M., R. K. Dennerle<strong>in</strong>, A. Kose <strong>and</strong> L. Scholtes (1992). '<strong>Health</strong> care <strong>in</strong> <strong>the</strong> EC<br />

member states.' <strong>Health</strong> Policy 20(1-2): 1-251.<br />

Schnitzler, F. (2003a). Personal communication, 3 March 2003.<br />

Schnitzler, F. (2003b). Personal correspondence, 3 April 2003.<br />

Schut, F. (2002). Personal communication.<br />

Schut, F. <strong>and</strong> E. van Doorslaer (1999). 'Towards a re<strong>in</strong>forced agency role <strong>of</strong> health <strong>in</strong>surers <strong>in</strong><br />

Belgium <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s.' <strong>Health</strong> Policy 48: 47-67.<br />

Schut, F. T. (1995). '<strong>Health</strong> care reform <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s: balanc<strong>in</strong>g corporatism, etatism,<br />

<strong>and</strong> market mechanisms.' J <strong>Health</strong> Polit Policy Law 20(3): 615-52.<br />

Sheldon, A. (2001). 'Dutch government plans to reform health <strong>in</strong>surance system.' British<br />

Medical Journal 323: 70.<br />

ter Meulen, R. <strong>and</strong> J. van der Made (2000). 'The extent <strong>and</strong> limits <strong>of</strong> solidarity <strong>in</strong> Dutch health<br />

care.' International Journal <strong>of</strong> Social Welfare 9: 250-260.<br />

van de Ven, W. P. M. M., R. C. J. A. van Vliet, F. T. Schut <strong>and</strong> E. M. van Barneveld (2000).<br />

'Access to coverage for high-risks <strong>in</strong> a competitive <strong>in</strong>dividual health <strong>in</strong>surance market:<br />

via premium rate restrictions or risk-adjusted premium subsidies?' Journal <strong>of</strong> <strong>Health</strong><br />

Economics 19: 311-339.<br />

Vektis (2000). Zorgmonitor. Zeist, Vektis.<br />

Vektis (2001). Zorg<strong>the</strong>rmometer 2001. Zeist, Vektis.<br />

Wasem, J. (1995). Regulat<strong>in</strong>g private health <strong>in</strong>surance markets. In Four country conference<br />

on health care reforms <strong>and</strong> health care policies <strong>in</strong> <strong>the</strong> United States, Canada,<br />

<strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, Amsterdam, February 23-25 1995. K. Okma, Ed.<br />

Amsterdam, M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong>, Welfare <strong>and</strong> Sport.<br />

Westerh<strong>out</strong>, E. (1999). 'The future <strong>of</strong> <strong>the</strong> Dutch health <strong>in</strong>surance system.' CPB Report<br />

1999(4): 21-26.<br />

i<br />

Substitutive VHI can be dist<strong>in</strong>guished from o<strong>the</strong>r types <strong>of</strong> VHI available with<strong>in</strong> <strong>the</strong> European Union. Complementary<br />

VHI is purchased to cover services only partially covered or excluded by <strong>the</strong> statutory health <strong>in</strong>surance scheme (for<br />

example, statutory user charges or dental care). Supplementary VHI is purchased to cover faster access <strong>and</strong><br />

<strong>in</strong>creased choice <strong>of</strong> treatment or provider.<br />

ii<br />

Private <strong>in</strong>surers had based <strong>the</strong>ir premium calculations on average life expectancy, fail<strong>in</strong>g to account for <strong>the</strong> longer<br />

than average life expectancy enjoyed by substitutive VHI policy holders, who tend to come from higher socioeconomic<br />

groups (Mossialos <strong>and</strong> Thomson 2002).<br />

iii<br />

From €41,400 to €45,900 per year. The contribution ceil<strong>in</strong>g <strong>and</strong> <strong>the</strong> threshold for return<strong>in</strong>g to <strong>the</strong> GKV rema<strong>in</strong> at<br />

€41,400.<br />

iv The average GKV contribution rate has also <strong>in</strong>creased over time, ris<strong>in</strong>g from 10.5 per cent <strong>of</strong> gross earn<strong>in</strong>gs <strong>in</strong><br />

1975 to 12.3 per cent <strong>in</strong> 1991, 13.6 per cent <strong>in</strong> 2000 <strong>and</strong> 14 per cent <strong>in</strong> 2002 (Busse 2002).<br />

v The average fee charged is €188 per person covered (exclud<strong>in</strong>g children covered as dependants) (den Exter<br />

2002).<br />

vi<br />

The WTZ now covers o<strong>the</strong>r groups, such as students whose parents are members <strong>of</strong> <strong>the</strong> ZFW.<br />

29


vii<br />

Changes to <strong>the</strong> <strong>in</strong>come threshold took place <strong>in</strong> 1994 (<strong>the</strong> van Otterloo Act), 1997 (an amendment to <strong>the</strong> Sickness<br />

Funds Act), 1998 (<strong>the</strong> <strong>Health</strong> <strong>Insurance</strong> (Restructur<strong>in</strong>g) Act) <strong>and</strong> 2000 (den Exter 2002).<br />

30

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!